<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE PubmedArticleSet SYSTEM "http://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">1</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2944</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>13</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical medicine</Title>
          <ISOAbbreviation>Biochem Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Formate assay in body fluids: application in methanol poisoning.</ArticleTitle>
        <Pagination>
          <MedlinePgn>117-26</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Makar</LastName>
            <ForeName>A B</ForeName>
            <Initials>AB</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>McMartin</LastName>
            <ForeName>K E</ForeName>
            <Initials>KE</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Palese</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tephly</LastName>
            <ForeName>T R</ForeName>
            <Initials>TR</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>MC_UU_12013/5</GrantID>
            <Agency>MRC</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochem Med</MedlineTA>
        <NlmUniqueID>0151424</NlmUniqueID>
        <ISSNLinking>0006-2944</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005561">Formates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>142M471B3J</RegistryNumber>
          <NameOfSubstance UI="D002245">Carbon Dioxide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.2.-</RegistryNumber>
          <NameOfSubstance UI="D000445">Aldehyde Oxidoreductases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>Y4S76JWI15</RegistryNumber>
          <NameOfSubstance UI="D000432">Methanol</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000445" MajorTopicYN="N">Aldehyde Oxidoreductases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001826" MajorTopicYN="N">Body Fluids</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002245" MajorTopicYN="N">Carbon Dioxide</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005561" MajorTopicYN="N">Formates</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000506" MajorTopicYN="Y">poisoning</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000882" MajorTopicYN="N">Haplorhini</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000432" MajorTopicYN="N">Methanol</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008722" MajorTopicYN="N">Methods</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011549" MajorTopicYN="N">Pseudomonas</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>6</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>6</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">1</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2944(75)90147-7</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">2</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1090-2104</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>66</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Oct</Month>
              <Day>27</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical and biophysical research communications</Title>
          <ISOAbbreviation>Biochem Biophys Res Commun</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Delineation of the intimate details of the backbone conformation of pyridine nucleotide coenzymes in aqueous solution.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1173-9</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bose</LastName>
            <ForeName>K S</ForeName>
            <Initials>KS</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sarma</LastName>
            <ForeName>R H</ForeName>
            <Initials>RH</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochem Biophys Res Commun</MedlineTA>
        <NlmUniqueID>0372516</NlmUniqueID>
        <ISSNLinking>0006-291X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0U46U6E8UK</RegistryNumber>
          <NameOfSubstance UI="D009243">NAD</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>53-59-8</RegistryNumber>
          <NameOfSubstance UI="D009249">NADP</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumIn">
          <RefSource>Biochem Pharmacol. 1975 Aug 15;24(16):1517-21</RefSource>
          <PMID Version="1">8</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005583" MajorTopicYN="N">Fourier Analysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008968" MajorTopicYN="N">Molecular Conformation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009243" MajorTopicYN="Y">NAD</DescriptorName>
          <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009249" MajorTopicYN="Y">NADP</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">2</ArticleId>
        <ArticleId IdType="pii">0006-291X(75)90482-9</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-291x(75)90482-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">3</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-291X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>66</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Oct</Month>
              <Day>27</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical and biophysical research communications</Title>
          <ISOAbbreviation>Biochem Biophys Res Commun</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Metal substitutions incarbonic anhydrase: a halide ion probe study.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1281-6</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>R J</ForeName>
            <Initials>RJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bryant</LastName>
            <ForeName>R G</ForeName>
            <Initials>RG</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochem Biophys Res Commun</MedlineTA>
        <NlmUniqueID>0372516</NlmUniqueID>
        <ISSNLinking>0006-291X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>00BH33GNGH</RegistryNumber>
          <NameOfSubstance UI="D002104">Cadmium</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 4.2.1.1</RegistryNumber>
          <NameOfSubstance UI="D002256">Carbonic Anhydrases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>FXS1BY2PGL</RegistryNumber>
          <NameOfSubstance UI="D008628">Mercury</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>J41CSQ7QDS</RegistryNumber>
          <NameOfSubstance UI="D015032">Zinc</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002104" MajorTopicYN="Y">Cadmium</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002256" MajorTopicYN="Y">Carbonic Anhydrases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008628" MajorTopicYN="Y">Mercury</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015032" MajorTopicYN="Y">Zinc</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">3</ArticleId>
        <ArticleId IdType="pii">0006-291X(75)90498-2</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-291x(75)90498-2</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">4</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1090-2104</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>66</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Oct</Month>
              <Day>27</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical and biophysical research communications</Title>
          <ISOAbbreviation>Biochem Biophys Res Commun</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effect of chloroquine on cultured fibroblasts: release of lysosomal hydrolases and inhibition of their uptake.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1338-43</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wiesmann</LastName>
            <ForeName>U N</ForeName>
            <Initials>UN</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>DiDonato</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Herschkowitz</LastName>
            <ForeName>N N</ForeName>
            <Initials>NN</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>BB/C008219/1</GrantID>
            <Agency>Biotechnology and Biological Sciences Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>G1100377</GrantID>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>G1100377</GrantID>
            <Agency>MRC</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochem Biophys Res Commun</MedlineTA>
        <NlmUniqueID>0372516</NlmUniqueID>
        <ISSNLinking>0006-291X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003911">Dextrans</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>886U3H6UFF</RegistryNumber>
          <NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.6.-</RegistryNumber>
          <NameOfSubstance UI="D013429">Sulfatases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.6.8</RegistryNumber>
          <NameOfSubstance UI="D002553">Cerebroside-Sulfatase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.2.1.31</RegistryNumber>
          <NameOfSubstance UI="D005966">Glucuronidase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001692" MajorTopicYN="N">Biological Transport</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002553" MajorTopicYN="N">Cerebroside-Sulfatase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003911" MajorTopicYN="N">Dextrans</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005966" MajorTopicYN="N">Glucuronidase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007966" MajorTopicYN="N">Leukodystrophy, Metachromatic</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010873" MajorTopicYN="N">Pinocytosis</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013429" MajorTopicYN="N">Sulfatases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">4</ArticleId>
        <ArticleId IdType="pii">0006-291X(75)90506-9</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-291x(75)90506-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">5</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1090-2104</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>66</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Oct</Month>
              <Day>27</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical and biophysical research communications</Title>
          <ISOAbbreviation>Biochem Biophys Res Commun</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Atomic models for the polypeptide backbones of myohemerythrin and hemerythrin.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1349-56</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hendrickson</LastName>
            <ForeName>W A</ForeName>
            <Initials>WA</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ward</LastName>
            <ForeName>K B</ForeName>
            <Initials>KB</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochem Biophys Res Commun</MedlineTA>
        <NlmUniqueID>0372516</NlmUniqueID>
        <ISSNLinking>0006-291X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006422">Hemerythrin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008667">Metalloproteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009124">Muscle Proteins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003063" MajorTopicYN="N">Cnidaria</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003201" MajorTopicYN="N">Computers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006422" MajorTopicYN="Y">Hemerythrin</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008667" MajorTopicYN="Y">Metalloproteins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009124" MajorTopicYN="Y">Muscle Proteins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">5</ArticleId>
        <ArticleId IdType="pii">0006-291X(75)90508-2</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-291x(75)90508-2</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">6</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-291X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>66</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Oct</Month>
              <Day>27</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical and biophysical research communications</Title>
          <ISOAbbreviation>Biochem Biophys Res Commun</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Studies of oxygen binding energy to hemoglobin molecule.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1424-31</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chow</LastName>
            <ForeName>Y W</ForeName>
            <Initials>YW</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pietranico</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mukerji</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochem Biophys Res Commun</MedlineTA>
        <NlmUniqueID>0372516</NlmUniqueID>
        <ISSNLinking>0006-291X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008024">Ligands</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010108">Oxyhemoglobins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>3G0H8C9362</RegistryNumber>
          <NameOfSubstance UI="D003035">Cobalt</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>E1UOL152H7</RegistryNumber>
          <NameOfSubstance UI="D007501">Iron</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>S88TT14065</RegistryNumber>
          <NameOfSubstance UI="D010100">Oxygen</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003035" MajorTopicYN="N">Cobalt</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006454" MajorTopicYN="Y">Hemoglobins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007501" MajorTopicYN="N">Iron</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008433" MajorTopicYN="N">Mathematics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010108" MajorTopicYN="N">Oxyhemoglobins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013057" MajorTopicYN="N">Spectrum Analysis</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">6</ArticleId>
        <ArticleId IdType="pii">0006-291X(75)90518-5</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-291x(75)90518-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">7</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1873-2968</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>16</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Aug</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Maturation of the adrenal medulla--IV. Effects of morphine.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1469-74</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Anderson</LastName>
            <ForeName>T R</ForeName>
            <Initials>TR</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Slotkin</LastName>
            <ForeName>T A</ForeName>
            <Initials>TA</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>MC_U147585819</GrantID>
            <Agency>MRC</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MC_UU_12011/1</GrantID>
            <Agency>MRC</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MC_UP_A620_1014</GrantID>
            <Agency>MRC</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002395">Catecholamines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>76I7G6D29C</RegistryNumber>
          <NameOfSubstance UI="D009020">Morphine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>818U2PZ2EH</RegistryNumber>
          <NameOfSubstance UI="D008680">Metaraminol</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.14.16.2</RegistryNumber>
          <NameOfSubstance UI="D014446">Tyrosine 3-Monooxygenase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.14.17.1</RegistryNumber>
          <NameOfSubstance UI="D004299">Dopamine beta-Hydroxylase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>YKH834O4BH</RegistryNumber>
          <NameOfSubstance UI="D004837">Epinephrine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000313" MajorTopicYN="N">Adrenal Medulla</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
          <QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002395" MajorTopicYN="N">Catecholamines</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004299" MajorTopicYN="N">Dopamine beta-Hydroxylase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004837" MajorTopicYN="N">Epinephrine</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008431" MajorTopicYN="N">Maternal-Fetal Exchange</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008680" MajorTopicYN="N">Metaraminol</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009020" MajorTopicYN="N">Morphine</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009021" MajorTopicYN="N">Morphine Dependence</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014446" MajorTopicYN="N">Tyrosine 3-Monooxygenase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>8</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>8</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>8</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">7</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90020-9</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90020-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Br J Gen Pract. 1999 Oct;49(447):823-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10885091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Gastroenterol Hepatol. 2000 Oct;15(10):1093-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11106086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Intern Med. 2001 Jul 3;135(1):68-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11434754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Viral Hepat. 2001 Sep;8(5):358-66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11555193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BJOG. 2002 Mar;109(3):227-35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11950176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drug Saf. 2002;25(5):323-44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12020172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Med. 2002 Oct 15;113(6):506-15</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12427501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Altern Complement Med. 2003 Feb;9(1):161-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12676044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychosomatics. 2003 Jul-Aug;44(4):271-82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12832592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aliment Pharmacol Ther. 2003 Sep 1;18(5):451-71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12950418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dig Dis Sci. 2003 Oct;48(10):1925-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14627335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cochrane Database Syst Rev. 2004;(1):CD002286</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14973986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mycoses. 2004 Apr;47(3-4):87-92</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15078424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Planta Med. 2004 Apr;70(4):293-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15095142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2004;4(1):49-67</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15273078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2003;3(2):69-90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15277068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2003;3(1):121-33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15277076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2002;2(3):49-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15277090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2002;2(1):71-85</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15277109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2004;4(2):63-78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15364646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Expert Opin Pharmacother. 2004 Dec;5(12):2485-501</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15571467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drug Saf. 2005;28(4):319-32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15783241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obstet Gynecol. 2005 Apr;105(4):849-56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15802416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2004;4(3):63-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15829470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obes Rev. 2005 May;6(2):93-111</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15836459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drug Saf. 2005;28(5):387-400</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15853441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2004;4(4):61-90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15927926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Semin Arthritis Rheum. 2005 Jun;34(6):773-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15942912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Expert Opin Drug Saf. 2005 Jul;4(4):779-94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16011454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2005;5(1):79-93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16093238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Complement Ther Med. 2005 Dec;13(4):279-90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16338199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phytomedicine. 2006 May;13(5):371-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16487688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2005;5(3):119-43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16520304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2005;5(4):71-114</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16635970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drug Saf. 2006;29(6):523-35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16752934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mov Disord. 2006 Oct;21(10):1709-15</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16830309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur Respir J. 2006 Aug;28(2):330-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16880367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2006;6(1):89-126</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17135164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2006;6(2):101-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17182489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2006;6(3-4):135-59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17317655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Toxicol. 2007;26 Suppl 1:3-106</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17365137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Psychiatry. 2007 May;190:379-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17470951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sleep Med Rev. 2007 Jun;11(3):209-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17517355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2007;7(1):99-113</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17594991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cochrane Database Syst Rev. 2007 Oct 17;(4):CD004559</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17943819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Can J Physiol Pharmacol. 2007 Sep;85(9):837-47</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18066129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World J Gastroenterol. 2008 Jan 21;14(3):454-62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18200670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Can J Clin Pharmacol. 2008 Winter;15(1):e66-73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18204101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2007;7(2):91-143</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18285310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Epidemiol. 1991;44(11):1271-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1834807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005288</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18425916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drug Saf. 2008;31(6):469-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18484782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cell Mol Neurobiol. 2009 Feb;29(1):17-25</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18584321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2007;7(3-4):143-77</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18928139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Herb Pharmacother. 2007;7(3-4):279-323</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18928148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evid Based Complement Alternat Med. 2009 Mar;6(1):99-105</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18955223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Obstet Gynecol. 2008 Nov;199(5):455-66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18984078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phytother Res. 2009 Apr;23(4):447-59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19086008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Soc Integr Oncol. 2009 Spring;7(2):73-80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19476742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cochrane Database Syst Rev. 2009 Jul 08;(3):CD006568</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19588398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drug Saf. 2009;32(8):637-47</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19591529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Gastroenterol Rep. 2009 Aug;11(4):317-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19615308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World J Gastroenterol. 2009 Oct 21;15(39):4886-95</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19842218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rev Recent Clin Trials. 2009 Sep;4(3):168-74</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20028328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006556</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20091597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cardiovasc Hematol Agents Med Chem. 2010 Apr;8(2):113-27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20370653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menopause. 2011 Apr;18(4):366-75</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21228727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Planta Med. 2011 Jul;77(11):1149-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21259185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cochrane Database Syst Rev. 2011 Feb 16;(2):CD002948</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21328257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maturitas. 2011 Sep;70(1):37-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21782365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Psychiatr Res. 2011 Nov;45(11):1518-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21820672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Complement Altern Med. 2011 Aug 28;11:72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21871125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Diet Suppl. 2010 Sep;7(3):283-302</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22432518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Diet Suppl. 2010 Dec;7(4):351-413</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22432564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Diet Suppl. 2011 Mar;8(1):58-114</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22432635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Diet Suppl. 2011 Jun;8(2):189-238</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22432689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Diet Suppl. 2011 Sep;8(3):311-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22432729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Diet Suppl. 2009;6(1):54-90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22435354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Diet Suppl. 2009;6(2):162-200</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22435415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Diet Suppl. 2010 Jun;7(2):179-215</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22435615</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">8</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1873-2968</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>16</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Aug</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison between procaine and isocarboxazid metabolism in vitro by a liver microsomal amidase-esterase.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1517-21</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Moroi</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sato</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>SF19107</GrantID>
            <Agency>Biotechnology and Biological Sciences Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016425">Published Erratum</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008670">Metals</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010743">Phospholipids</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>34237V843T</RegistryNumber>
          <NameOfSubstance UI="D007520">Isocarboxazid</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>4Z8Y51M438</RegistryNumber>
          <NameOfSubstance UI="D011343">Procaine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.-</RegistryNumber>
          <NameOfSubstance UI="D004950">Esterases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.5.-</RegistryNumber>
          <NameOfSubstance UI="D000581">Amidohydrolases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumFor">
          <RefSource>Biochem Biophys Res Commun. 1975 Oct 27;66(4):1173-9</RefSource>
          <PMID Version="1">2</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000581" MajorTopicYN="N">Amidohydrolases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004950" MajorTopicYN="N">Esterases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007520" MajorTopicYN="N">Isocarboxazid</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008670" MajorTopicYN="N">Metals</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010743" MajorTopicYN="N">Phospholipids</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011343" MajorTopicYN="N">Procaine</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013347" MajorTopicYN="N">Subcellular Fractions</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>8</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>8</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>8</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">8</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90029-5</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90029-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Nature. 2001 May 31;411(6837):599-603</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11385576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastroenterology. 2003 Jul;125(1):47-57</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12851870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Best Pract Res Clin Gastroenterol. 2004 Jun;18(3):525-39</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15157825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastroenterology. 2004 Oct;127(4):1051-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15480983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2004 Nov 11;351(20):2069-79</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15537905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Med. 2005 Apr;11(4):383-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15812518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Colorectal Dis. 2006 Dec;21(8):747-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16228179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World J Gastroenterol. 2006 Apr 7;12(13):1991-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16610046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Gastroenterol. 2006 Jul;101(7):1559-68</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16863561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Science. 2006 Dec 1;314(5804):1461-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17068223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Immunogenet. 2007 Jun;34(3):181-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17504508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Rev Genet. 2008 Jan;9(1):9-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17968351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Genet. 2008 Aug;40(8):955-62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18587394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inflamm Bowel Dis. 2008 Nov;14(11):1469-82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18618634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gut. 2008 Sep;57(9):1294-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18719139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 2008 Nov 13;456(7219):259-63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18849966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Annu Rev Genomics Hum Genet. 2009;10:89-116</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19453248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inflamm Bowel Dis. 2009 Nov;15(11):1643-55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19462429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Immunol. 2009 Oct;10(10):1073-80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19701189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15813-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19805227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):513-34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19817673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Immunol. 2010 Jan;11(1):55-62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19898471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Gastroenterol Rep. 2009 Dec;11(6):481-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19903424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Med. 2010 Jan;16(1):90-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19966812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inflamm Bowel Dis. 2010 Jul;16(7):1108-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20024904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Gastroenterol. 2010 Aug;105(8):1811-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20197757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Opin Gastroenterol. 2010 Jul;26(4):327-31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20445446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Immunol. 2010 Jun 15;184(12):7247-56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20483763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inflamm Bowel Dis. 2011 Jan;17(1):346-61</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20839313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Genet. 2010 Dec;42(12):1118-25</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21102463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastroenterology. 1989 Apr;96(4):1016-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2925048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gut. 1988 Jul;29(7):990-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3396969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 1996 Feb 29;379(6568):821-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8587604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastroenterology. 1996 Sep;111(3):597-603</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8780562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gut. 1996 Nov;39(5):690-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9014768</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">9</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2952</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>24</Volume>
            <Issue>17</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Radiochemical assay of glutathione S-epoxide transferase and its enhancement by phenobarbital in rat liver in vivo.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1569-72</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Marniemi</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Parkki</LastName>
            <ForeName>M G</ForeName>
            <Initials>MG</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004852">Epoxy Compounds</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013343">Styrenes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>56-49-5</RegistryNumber>
          <NameOfSubstance UI="D008748">Methylcholanthrene</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.5.1.18</RegistryNumber>
          <NameOfSubstance UI="D005982">Glutathione Transferase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>GAN16C9B8O</RegistryNumber>
          <NameOfSubstance UI="D005978">Glutathione</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>YQE403BP4D</RegistryNumber>
          <NameOfSubstance UI="D010634">Phenobarbital</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004852" MajorTopicYN="N">Epoxy Compounds</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005982" MajorTopicYN="N">Glutathione Transferase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008748" MajorTopicYN="N">Methylcholanthrene</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013268" MajorTopicYN="N">Stimulation, Chemical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013343" MajorTopicYN="N">Styrenes</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">9</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90080-5</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90080-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">10</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1873-2968</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>17</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Digitoxin metabolism by rat liver microsomes.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1639-41</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Schmoldt</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Benthe</LastName>
            <ForeName>H F</ForeName>
            <Initials>HF</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haberland</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>K01 AG044439</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>143-62-4</RegistryNumber>
          <NameOfSubstance UI="D004073">Digitoxigenin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>53-59-8</RegistryNumber>
          <NameOfSubstance UI="D009249">NADP</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>E90NZP2L9U</RegistryNumber>
          <NameOfSubstance UI="D004074">Digitoxin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002855" MajorTopicYN="N">Chromatography, Thin Layer</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004073" MajorTopicYN="N">Digitoxigenin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004074" MajorTopicYN="N">Digitoxin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006900" MajorTopicYN="N">Hydroxylation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009249" MajorTopicYN="N">NADP</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">10</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90094-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">11</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2952</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>24</Volume>
            <Issue>18</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Identification of adenylate cyclase-coupled beta-adrenergic receptors with radiolabeled beta-adrenergic antagonists.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1651-8</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lefkowitz</LastName>
            <ForeName>R J</ForeName>
            <Initials>RJ</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002395">Catecholamines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011941">Receptors, Adrenergic</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>10028-17-8</RegistryNumber>
          <NameOfSubstance UI="D014316">Tritium</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>877K5MQ27W</RegistryNumber>
          <NameOfSubstance UI="D000526">Alprenolol</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9Y8NXQ24VQ</RegistryNumber>
          <NameOfSubstance UI="D011433">Propranolol</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 4.6.1.1</RegistryNumber>
          <NameOfSubstance UI="D000262">Adenylyl Cyclases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>L628TT009W</RegistryNumber>
          <NameOfSubstance UI="D007545">Isoproterenol</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000262" MajorTopicYN="N">Adenylyl Cyclases</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000526" MajorTopicYN="N">Alprenolol</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001001" MajorTopicYN="N">Anura</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002395" MajorTopicYN="N">Catecholamines</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004524" MajorTopicYN="N">Eels</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007545" MajorTopicYN="N">Isoproterenol</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011433" MajorTopicYN="N">Propranolol</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011941" MajorTopicYN="N">Receptors, Adrenergic</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013237" MajorTopicYN="N">Stereoisomerism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014316" MajorTopicYN="N">Tritium</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">11</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90001-5</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90001-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Am Coll Cardiol. 2002 Jul 3;40(1):142-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12103268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Postgrad Med J. 2005 Jul;81(957):442-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15998820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur Heart J. 2006 Feb;27(3):344-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16223744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heart. 2006 Apr;92(4):559-68</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16537784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Europace. 2006 Sep;8(9):746-837</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16935866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur Heart J. 2007 Sep;28(18):2256-95</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17726042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Electrophysiol. 2008 Jan;19(1):48-55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17916139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>QJM. 2009 Jul;102(7):485-90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19474111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur Heart J. 2009 Nov;30(21):2631-71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19713422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Intern Med. 1997 Jun 15;126(12):989-96</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9182479</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">12</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2952</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>24</Volume>
            <Issue>18</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The effect of adrenaline and of alpha- and beta-adrenergic blocking agents on ATP concentration and on incorporation of 32Pi into ATP in rat fat cells.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1659-62</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stein</LastName>
            <ForeName>J M</ForeName>
            <Initials>JM</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>G1002528</GrantID>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000317">Adrenergic alpha-Antagonists</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010761">Phosphorus Radioisotopes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0TTZ664R7Z</RegistryNumber>
          <NameOfSubstance UI="D010643">Phenoxybenzamine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>27YLU75U4W</RegistryNumber>
          <NameOfSubstance UI="D010758">Phosphorus</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>8L70Q75FXE</RegistryNumber>
          <NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9Y8NXQ24VQ</RegistryNumber>
          <NameOfSubstance UI="D011433">Propranolol</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.13.12.-</RegistryNumber>
          <NameOfSubstance UI="D008156">Luciferases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.1.1</RegistryNumber>
          <NameOfSubstance UI="D006593">Hexokinase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>YKH834O4BH</RegistryNumber>
          <NameOfSubstance UI="D004837">Epinephrine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName>
          <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000317" MajorTopicYN="N">Adrenergic alpha-Antagonists</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004837" MajorTopicYN="N">Epinephrine</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006593" MajorTopicYN="N">Hexokinase</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008156" MajorTopicYN="N">Luciferases</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010643" MajorTopicYN="N">Phenoxybenzamine</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010758" MajorTopicYN="N">Phosphorus</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010761" MajorTopicYN="N">Phosphorus Radioisotopes</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011433" MajorTopicYN="N">Propranolol</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">12</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90002-7</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90002-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Int J Qual Health Care. 2007 Feb;19(1):50-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17172600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nurse Educ Pract. 2008 Sep;8(5):299-301</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18692016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2009 Apr 21;338:b1555</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19383750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2009 May 12;338:b1900</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19435768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2011 Feb 03;342:c6646</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21292716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2011 Sep 13;343:d5672</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21914758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ Qual Saf. 2012 Mar;21(3):234-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22282817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Med (Lond). 2012 Dec;12(6):520-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23342404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ Qual Saf. 2013 Aug;22(8):613-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23661281</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">13</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2952</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>24</Volume>
            <Issue>18</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Action of propranolol on mitochondrial functions--effects on energized ion fluxes in the presence of valinomycin.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1701-5</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Järvisalo</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saris</LastName>
            <ForeName>N E</ForeName>
            <Initials>NE</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>G9901400</GrantID>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>2001-95-8</RegistryNumber>
          <NameOfSubstance UI="D014634">Valinomycin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>8L70Q75FXE</RegistryNumber>
          <NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9Y8NXQ24VQ</RegistryNumber>
          <NameOfSubstance UI="D011433">Propranolol</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.6.1.-</RegistryNumber>
          <NameOfSubstance UI="D000251">Adenosine Triphosphatases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>RRU6GY95IS</RegistryNumber>
          <NameOfSubstance UI="D009550">Nigericin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>RWP5GA015D</RegistryNumber>
          <NameOfSubstance UI="D011188">Potassium</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000251" MajorTopicYN="N">Adenosine Triphosphatases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008930" MajorTopicYN="N">Mitochondria, Liver</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008933" MajorTopicYN="N">Mitochondrial Swelling</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009550" MajorTopicYN="N">Nigericin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010085" MajorTopicYN="N">Oxidative Phosphorylation</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011188" MajorTopicYN="N">Potassium</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011433" MajorTopicYN="N">Propranolol</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014634" MajorTopicYN="N">Valinomycin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">13</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90009-X</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90009-x</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">14</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2952</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>24</Volume>
            <Issue>18</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Malathion A and B esterases of mouse liver-I.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1713-7</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bhagwat</LastName>
            <ForeName>V M</ForeName>
            <Initials>VM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramachandran</LastName>
            <ForeName>B V</ForeName>
            <Initials>BV</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>G0100165</GrantID>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008670">Metals</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013438">Sulfhydryl Compounds</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.-</RegistryNumber>
          <NameOfSubstance UI="D004950">Esterases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>U5N7SU872W</RegistryNumber>
          <NameOfSubstance UI="D008294">Malathion</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004355" MajorTopicYN="N">Drug Stability</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004950" MajorTopicYN="N">Esterases</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
          <QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008294" MajorTopicYN="N">Malathion</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008670" MajorTopicYN="N">Metals</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013438" MajorTopicYN="N">Sulfhydryl Compounds</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">14</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90011-8</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90011-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Nature. 2003 Jan 2;421(6918):37-42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12511946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proc Biol Sci. 2003 Sep 22;270(1527):1887-92</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14561301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 2004 Jan 8;427(6970):145-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14712274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 2006 Jan 12;439(7073):161-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16407945</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">15</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2952</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>24</Volume>
            <Issue>18</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Increase in acetyl CoA synthetase activity after phenobarbital treatment.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1725-7</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Akamatsu</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakajima</LastName>
            <ForeName>H</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ono</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miura</LastName>
            <ForeName>Y</ForeName>
            <Initials>Y</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>98600C0908</RegistryNumber>
          <NameOfSubstance UI="D003513">Cycloheximide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.6.1.16</RegistryNumber>
          <NameOfSubstance UI="D005945">Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.-</RegistryNumber>
          <NameOfSubstance UI="D010770">Phosphotransferases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.1.6</RegistryNumber>
          <NameOfSubstance UI="D000115">Acetylesterase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 6.2.1.-</RegistryNumber>
          <NameOfSubstance UI="D003066">Coenzyme A Ligases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 6.2.1.1</RegistryNumber>
          <NameOfSubstance UI="D000106">Acetate-CoA Ligase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N08U5BOQ1K</RegistryNumber>
          <NameOfSubstance UI="D005944">Glucosamine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>V956696549</RegistryNumber>
          <NameOfSubstance UI="D000117">Acetylglucosamine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>YQE403BP4D</RegistryNumber>
          <NameOfSubstance UI="D010634">Phenobarbital</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000106" MajorTopicYN="N">Acetate-CoA Ligase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000115" MajorTopicYN="N">Acetylesterase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000117" MajorTopicYN="N">Acetylglucosamine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003066" MajorTopicYN="N">Coenzyme A Ligases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003513" MajorTopicYN="N">Cycloheximide</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005944" MajorTopicYN="N">Glucosamine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005945" MajorTopicYN="N">Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010770" MajorTopicYN="N">Phosphotransferases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013268" MajorTopicYN="N">Stimulation, Chemical</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">15</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90013-1</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90013-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Clin Med (Lond). 2005 Jul-Aug;5(4):344-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16138488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Dis Child. 2007 Jul;92(7):573-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17588971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Dis Child. 2007 Dec;92(12):1143</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18032643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pediatrics. 2010 Nov;126(5):851-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20956413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Health Serv Res Policy. 2011 Apr;16(2):75-80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21389060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2011 Apr 18;342:d2421</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21502273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Med (Lond). 2011 Oct;11(5):420-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22034695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bull Hist Med. 1998 Summer;72(2):246-78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9628051</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">16</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2952</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>24</Volume>
            <Issue>18</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1731-3</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Turner</LastName>
            <ForeName>A J</ForeName>
            <Initials>AJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hick</LastName>
            <ForeName>P E</ForeName>
            <Initials>PE</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001679">Biogenic Amines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>53-59-8</RegistryNumber>
          <NameOfSubstance UI="D009249">NADP</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.2.-</RegistryNumber>
          <NameOfSubstance UI="D000445">Aldehyde Oxidoreductases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>X77S6GMS36</RegistryNumber>
          <NameOfSubstance UI="D006719">Homovanillic Acid</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000445" MajorTopicYN="N">Aldehyde Oxidoreductases</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001679" MajorTopicYN="N">Biogenic Amines</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006719" MajorTopicYN="N">Homovanillic Acid</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009249" MajorTopicYN="N">NADP</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012756" MajorTopicYN="N">Sheep</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">16</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90016-7</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90016-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 2000 Feb;85(2):637-44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10690869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>NIH Consens State Sci Statements. 2002 Feb 4-6;19(2):1-25</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14768652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endocr Rev. 2004 Apr;25(2):309-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15082524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Endocrinol Invest. 2006 Apr;29(4):298-302</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16699294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2007 Feb 8;356(6):601-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17287480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endocr Pract. 2008 Apr;14(3):279-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18463033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endocr Pract. 2009 Jul-Aug;15 Suppl 1:1-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19632967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endocrine. 2010 Feb;37(1):40-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19882253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 2010 Sep;95(9):4106-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20823463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endocrine. 2011 Aug;40(1):80-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21547511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endocrine. 2011 Aug;40(1):134-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21562920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Surg. 2011 Oct;98(10):1383-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21618498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horm Metab Res. 2011 Dec;43(13):962-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22048862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2012 May 28;344:e3502</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22645185</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">17</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2952</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>24</Volume>
            <Issue>18</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effects of 5,6-dihydroxytryptamine on tyrosine-hydroxylase activity in central catecholaminergic neurons of the rat.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1739-42</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Renaud</LastName>
            <ForeName>B</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Buda</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lewis</LastName>
            <ForeName>B D</ForeName>
            <Initials>BD</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pujol</LastName>
            <ForeName>J F</ForeName>
            <Initials>JF</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>HERU1</GrantID>
            <Acronym>CSO_</Acronym>
            <Agency>Chief Scientist Office</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002395">Catecholamines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014363">Tryptamines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.14.16.2</RegistryNumber>
          <NameOfSubstance UI="D014446">Tyrosine 3-Monooxygenase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>W2QY253O8S</RegistryNumber>
          <NameOfSubstance UI="D015115">5,6-Dihydroxytryptamine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015115" MajorTopicYN="N">5,6-Dihydroxytryptamine</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002395" MajorTopicYN="N">Catecholamines</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002946" MajorTopicYN="N">Cisterna Magna</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003342" MajorTopicYN="N">Corpus Striatum</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007267" MajorTopicYN="N">Injections</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013268" MajorTopicYN="N">Stimulation, Chemical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013378" MajorTopicYN="N">Substantia Nigra</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014363" MajorTopicYN="N">Tryptamines</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014446" MajorTopicYN="N">Tyrosine 3-Monooxygenase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">17</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90018-0</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90018-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>BMJ. 2010 Apr 20;340:c2016</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20406861</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">18</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2952</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>24</Volume>
            <Issue>20</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Oct</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Inhibition of aldehyde reductase isoenzymes in human and rat brain.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1865-9</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ris</LastName>
            <ForeName>M M</ForeName>
            <Initials>MM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deitrich</LastName>
            <ForeName>R A</ForeName>
            <Initials>RA</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Von Wartburg</LastName>
            <ForeName>J P</ForeName>
            <Initials>JP</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001463">Barbiturates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006827">Hydantoins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007527">Isoenzymes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013388">Succinimides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0U46U6E8UK</RegistryNumber>
          <NameOfSubstance UI="D009243">NAD</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>53-59-8</RegistryNumber>
          <NameOfSubstance UI="D009249">NADP</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>C8I4BVN78E</RegistryNumber>
          <NameOfSubstance UI="D005984">Glutethimide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.2.-</RegistryNumber>
          <NameOfSubstance UI="D000445">Aldehyde Oxidoreductases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000445" MajorTopicYN="N">Aldehyde Oxidoreductases</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001463" MajorTopicYN="N">Barbiturates</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005984" MajorTopicYN="N">Glutethimide</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006827" MajorTopicYN="N">Hydantoins</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009243" MajorTopicYN="N">NAD</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009249" MajorTopicYN="N">NADP</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013388" MajorTopicYN="N">Succinimides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">18</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90405-0</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90405-0</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">19</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2952</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>24</Volume>
            <Issue>20</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Oct</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Antidepressant drugs affect dopamine uptake.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1896-7</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Halaris</LastName>
            <ForeName>A E</ForeName>
            <Initials>AE</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Belendiuk</LastName>
            <ForeName>K T</ForeName>
            <Initials>KT</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Freedman</LastName>
            <ForeName>D X</ForeName>
            <Initials>DX</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000697">Central Nervous System Stimulants</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>VTD58H1Z2X</RegistryNumber>
          <NameOfSubstance UI="D004298">Dopamine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000697" MajorTopicYN="N">Central Nervous System Stimulants</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003864" MajorTopicYN="N">Depression, Chemical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">19</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90412-8</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90412-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>JAMA. 2001 Jun 13;285(22):2871-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11401608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Care. 2001 Aug;39(8 Suppl 2):II2-45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11583120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Health Serv Manage Res. 2002 May;15(2):126-37</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12028801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qual Saf Health Care. 2003 Dec;12(6):458-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14645763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Soc Nephrol. 2004 Mar;15(3):754-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14978178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancet. 2004 Apr 3;363(9415):1147-54</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15064036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2005 Apr 2;330(7494):781-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15802723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Coll Cardiol. 2005 Oct 4;46(7):1236-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16198837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milbank Q. 2005;83(4):691-729</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16279964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JAMA. 2006 Jan 18;295(3):324-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16418469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2006 Nov 30;355(22):2308-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17101617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Eval Clin Pract. 2007 Apr;13(2):161-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17378860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2007 Aug 9;357(6):608-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17687138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qual Saf Health Care. 2007 Oct;16(5):387-99</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17913782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2008 Jun 28;336(7659):1491-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18577559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2008 Aug 13;337:a957</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18703659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JAMA. 2008 Dec 24;300(24):2913-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19109120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Med (Lond). 2009 Apr;9(2):140-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19435119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2009 Nov 19;339:b4809</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19926689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2009 Nov 19;339:b4811</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19926690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2010 Mar 31;340:c1234</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20360220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2010 Apr 20;340:c2016</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20406861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2010 Apr 23;340:c2153</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20418546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2010 Jul 1;363(1):45-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20463332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2010 Aug 13;341:c4078</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20709715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2010 Dec 23;363(26):2477-81</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21142528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Soc Nephrol. 2011 Feb;22(2):225-34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21289212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2011 Feb 03;342:d199</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21292720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Med (Lond). 2010 Dec;10(6):537-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21413472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nephron Clin Pract. 2011;119(1):c10-7; discussion c17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21659780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kidney Int. 2011 Nov;80(10):1021-34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21775971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Implement Sci. 2011 Oct 24;6:119</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22024188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2012 Mar 01;344:e1001</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22381521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Methods Inf Med. 2012;51(3):189-98</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22476327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Intern Med. 1998 Feb 15;128(4):289-92</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9471932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Qual Health Care. 1998 Oct;10(5):443-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9828034</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">20</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2952</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>24</Volume>
            <Issue>20</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Oct</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemical pharmacology</Title>
          <ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Aggregation of blood platelets by adrenaline and its uptake.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1903-4</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Barthel</LastName>
            <ForeName>W</ForeName>
            <Initials>W</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Markwardt</LastName>
            <ForeName>F</ForeName>
            <Initials>F</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biochem Pharmacol</MedlineTA>
        <NlmUniqueID>0101032</NlmUniqueID>
        <ISSNLinking>0006-2952</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>436O5HM03C</RegistryNumber>
          <NameOfSubstance UI="D004087">Dihydroergotamine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>8NA5SWF92O</RegistryNumber>
          <NameOfSubstance UI="D008238">Lysergic Acid Diethylamide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>YKH834O4BH</RegistryNumber>
          <NameOfSubstance UI="D004837">Epinephrine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001792" MajorTopicYN="N">Blood Platelets</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004087" MajorTopicYN="N">Dihydroergotamine</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004837" MajorTopicYN="N">Epinephrine</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008238" MajorTopicYN="N">Lysergic Acid Diethylamide</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010974" MajorTopicYN="N">Platelet Aggregation</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011817" MajorTopicYN="N">Rabbits</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>15</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">20</ArticleId>
        <ArticleId IdType="pii">0006-2952(75)90415-3</ArticleId>
        <ArticleId IdType="doi">10.1016/0006-2952(75)90415-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Int J Qual Health Care. 2008 Feb;20(1):22-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18073269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qual Health Res. 2008 Mar;18(3):380-90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18235161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2009 Jan 29;360(5):491-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19144931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Educ. 1998 May;32(3):239-43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9743776</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">21</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2017</Year>
        <Month>03</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0004-4172</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>25</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Arzneimittel-Forschung</Title>
          <ISOAbbreviation>Arzneimittelforschung</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Biochemical studies on camomile components/III. In vitro studies about the antipeptic activity of (--)-alpha-bisabolol (author's transl)].</ArticleTitle>
        <Pagination>
          <MedlinePgn>1352-4</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>(--)-alpha-Bisabolol has a primary antipeptic action depending on dosage, which is not caused by an alteration of the pH-value. The proteolytic activity of pepsin is reduced by 50 percent through addition of bisabolol in the ratio of 1/0.5. The antipeptic action of bisabolol only occurs in case of direct contact. In case of a previous contact with the substrate, the inhibiting effect is lost.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Isaac</LastName>
            <ForeName>O</ForeName>
            <Initials>O</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thiemer</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
          </Author>
        </AuthorList>
        <Language>ger</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Biochemische Untersuchungen von Kamilleninhaltsstoffen. III. In-vitro-Versuche über die antipeptische Wirkung des (-)-alpha-Bisabolols</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Arzneimittelforschung</MedlineTA>
        <NlmUniqueID>0372660</NlmUniqueID>
        <ISSNLinking>0004-4172</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012717">Sesquiterpenes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>42HK56048U</RegistryNumber>
          <NameOfSubstance UI="D014443">Tyrosine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>5V2JDO056X</RegistryNumber>
          <NameOfSubstance UI="D014238">Trichloroacetic Acid</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.23.1</RegistryNumber>
          <NameOfSubstance UI="D010434">Pepsin A</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008722" MajorTopicYN="N">Methods</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010434" MajorTopicYN="N">Pepsin A</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010946" MajorTopicYN="N">Plants, Medicinal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012717" MajorTopicYN="N">Sesquiterpenes</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013056" MajorTopicYN="N">Spectrophotometry, Ultraviolet</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014238" MajorTopicYN="N">Trichloroacetic Acid</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014443" MajorTopicYN="N">Tyrosine</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">21</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">22</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0004-4172</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>25</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Arzneimittel-Forschung</Title>
          <ISOAbbreviation>Arzneimittelforschung</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a N-(2-cyanoethylene)-urea. Novel prophylactic possibilities].</ArticleTitle>
        <Pagination>
          <MedlinePgn>1369-79</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>A report is given on the recent discovery of outstanding immunological properties in BA 1 [N-(2-cyanoethylene)-urea] having a (low) molecular mass M = 111.104. Experiments in 214 DS carcinosarcoma bearing Wistar rats have shown that BA 1, at a dosage of only about 12 percent LD50 (150 mg kg) and negligible lethality (1.7 percent), results in a recovery rate of 40 percent without hyperglycemia and, in one test, of 80 percent with hyperglycemia. Under otherwise unchanged conditions the reference substance ifosfamide (IF) -- a further development of cyclophosphamide -- applied without hyperglycemia in its most efficient dosage of 47 percent LD50 (150 mg kg) brought about a recovery rate of 25 percent at a lethality of 18 percent. (Contrary to BA 1, 250-min hyperglycemia caused no further improvement of the recovery rate.) However this comparison is characterized by the fact that both substances exhibit two quite different (complementary) mechanisms of action. Leucocyte counts made after application of the said cancerostatics and dosages have shown a pronounced stimulation with BA 1 and with ifosfamide, the known suppression in the post-therapeutic interval usually found with standard cancerostatics. In combination with the cited plaque test for BA 1, blood pictures then allow conclusions on the immunity status. Since IF can be taken as one of the most efficient cancerostatics--there is no other chemotherapeutic known up to now that has a more significant effect on the DS carcinosarcoma in rats -- these findings are of special importance. Finally, the total amount of leucocytes and lymphocytes as well as their time behaviour was determined from the blood picture of tumour-free rats after i.v. application of BA 1. The thus obtained numerical values clearly show that further research work on the prophylactic use of this substance seems to be necessary and very promising.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ardenne</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reitnauer</LastName>
            <ForeName>P G</ForeName>
            <Initials>PG</Initials>
          </Author>
        </AuthorList>
        <Language>ger</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Nachweis krebshemmender Eigenschaften einer stark immunstimulierenden Verbindung kleiner Molekülmasse. Versuche am immunlabilen DS-Karzinosarkom im Vergleich mit Ifosfamid. Stimulierung der körpereigenen Abwehr über etwa 20 Tage durch BA 1, einen N-(2-Cyanthylen)-harnstoff. Neue prophylaktische Möglichkeiten</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Arzneimittelforschung</MedlineTA>
        <NlmUniqueID>0372660</NlmUniqueID>
        <ISSNLinking>0004-4172</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>8N3DW7272P</RegistryNumber>
          <NameOfSubstance UI="D003520">Cyclophosphamide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>8W8T17847W</RegistryNumber>
          <NameOfSubstance UI="D014508">Urea</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>UM20QQM95Y</RegistryNumber>
          <NameOfSubstance UI="D007069">Ifosfamide</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002296" MajorTopicYN="N">Carcinosarcoma</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003520" MajorTopicYN="N">Cyclophosphamide</DescriptorName>
          <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004361" MajorTopicYN="N">Drug Tolerance</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004906" MajorTopicYN="N">Erythrocyte Count</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006943" MajorTopicYN="N">Hyperglycemia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007069" MajorTopicYN="Y">Ifosfamide</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007165" MajorTopicYN="N">Immunosuppression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007928" MajorTopicYN="N">Lethal Dose 50</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007958" MajorTopicYN="N">Leukocyte Count</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009374" MajorTopicYN="N">Neoplasms, Experimental</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013268" MajorTopicYN="N">Stimulation, Chemical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014508" MajorTopicYN="N">Urea</DescriptorName>
          <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">22</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Crit Care Med. 2006 Jul;34(7):1913-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16715038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crit Care. 2007;11(2):R31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17331245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Soc Nephrol. 2010 Feb;21(2):345-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20019168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Kidney Dis. 2010 Oct;56(4):651-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20673605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blood Purif. 2010;30(2):120-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20714143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nephrol Dial Transplant. 2011 Jul;26(7):2161-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21148028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Kidney Dis. 2011 Feb;57(2):228-34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21195518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin J Am Soc Nephrol. 2012 Apr;7(4):533-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22362062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>QJM. 2012 Aug;105(8):729-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22408153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin J Am Soc Nephrol. 2012 May;7(5):712-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22422536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>QJM. 2013 Apr;106(4):323-32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23345468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J R Coll Physicians Edinb. 2013;43(1):37-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23516690</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">23</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0004-4172</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>25</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Arzneimittel-Forschung</Title>
          <ISOAbbreviation>Arzneimittelforschung</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effect of etafenone on total and regional myocardial blood flow.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1400-3</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>The distribution of blood flow to the subendocardial, medium and subepicardial layers of the left ventricular free wall was studied in anaesthetized dogs under normoxic (A), hypoxic (B) conditions and under pharmacologically induced (etafenone) coronary vasodilation (C). Regional myocardial blood flow was determined by means of the particle distribution method. In normoxia a transmural gradient of flow was observed, with the subendocardial layers receiving a significantly higher flow rate compared with the subepicardial layers. In hypoxia induced vasodilation this transmural gradient of flow was persistent. In contrast a marked redistribution of regional flow was observed under pharmacologically induced vasodilation. The transmural gradient decreased. In contrast to some findings these experiments demonstrate that a considerable vasodilatory capacity exists in all layers of the myocardium and can be utilized by drugs. The differences observed for the intramural distribution pattern of flow under hypoxia and drug induced vasodilation support the hypothesis that this pattern reflects corresponding gradients of regional myocardial metabolism.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Flohr</LastName>
            <ForeName>H</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Breull</LastName>
            <ForeName>W</ForeName>
            <Initials>W</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>G0700399</GrantID>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Arzneimittelforschung</MedlineTA>
        <NlmUniqueID>0372660</NlmUniqueID>
        <ISSNLinking>0004-4172</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011427">Propiophenones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014665">Vasodilator Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>142M471B3J</RegistryNumber>
          <NameOfSubstance UI="D002245">Carbon Dioxide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>S88TT14065</RegistryNumber>
          <NameOfSubstance UI="D010100">Oxygen</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002245" MajorTopicYN="N">Carbon Dioxide</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002302" MajorTopicYN="N">Cardiac Output</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003326" MajorTopicYN="N">Coronary Circulation</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003331" MajorTopicYN="N">Coronary Vessels</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006346" MajorTopicYN="N">Heart Septum</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006352" MajorTopicYN="N">Heart Ventricles</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011427" MajorTopicYN="N">Propiophenones</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014665" MajorTopicYN="N">Vasodilator Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">23</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Appl Psychol. 2001 Aug;86(4):730-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11519656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>South Med J. 2005 May;98(5):528-32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15954509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Crit Care. 2008 Jun;23(2):167-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18538207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Educ. 2009 Jan;43(1):50-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19140997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Med (Lond). 2009 Oct;9(5):417-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19886098</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">24</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0004-4172</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>25</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Arzneimittel-Forschung</Title>
          <ISOAbbreviation>Arzneimittelforschung</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Influence of a new virostatic compound on the induction of enzymes in rat liver.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1426-9</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>The virostatic compound N,N-diethyl-4-[2-(2-oxo-3-tetradecyl-1-imidazolidinyl)-ethyl]-1-piperazinecarboxamide-hydrochloride (5531) was analyzed as to its effect on the induction of tryptophan-pyrrolase and tyrosineaminotransferase in rat liver. 1. The basic activity of the enzymes was not influenced by the substance either in normal or in adrenalectomized animals. 2. The induction of the enzymes by cortisone increased in the presence of the compound whereas the substrate induction remained unchanged. 3. The induction of tyrosine-aminotransferase by dexamethasonephosphate in tissue culture is inhibited if the dose of compound 5531 is higher than 5 mug/ml.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kröger</LastName>
            <ForeName>H</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Donner</LastName>
            <ForeName>I</ForeName>
            <Initials>I</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Skiello</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Arzneimittelforschung</MedlineTA>
        <NlmUniqueID>0372660</NlmUniqueID>
        <ISSNLinking>0004-4172</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007093">Imidazoles</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010879">Piperazines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>42HK56048U</RegistryNumber>
          <NameOfSubstance UI="D014443">Tyrosine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.13.11.11</RegistryNumber>
          <NameOfSubstance UI="D014366">Tryptophan Oxygenase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.6.1.5</RegistryNumber>
          <NameOfSubstance UI="D014444">Tyrosine Transaminase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>V27W9254FZ</RegistryNumber>
          <NameOfSubstance UI="D003348">Cortisone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000315" MajorTopicYN="N">Adrenalectomy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003348" MajorTopicYN="N">Cortisone</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D046508" MajorTopicYN="N">Culture Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007093" MajorTopicYN="N">Imidazoles</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014366" MajorTopicYN="N">Tryptophan Oxygenase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014443" MajorTopicYN="N">Tyrosine</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014444" MajorTopicYN="N">Tyrosine Transaminase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Clin Med (Lond). 2008 Feb;8(1):61-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18335672</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">25</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2017</Year>
        <Month>03</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0004-4172</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>25</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Arzneimittel-Forschung</Title>
          <ISOAbbreviation>Arzneimittelforschung</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pharmacological properties of new neuroleptic compounds.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1436-42</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>RMI 61 140, RMI 61 144 and RMI 61 280 are newly synthetized N-[8-R-dibenzo(b,f)oxepin-10-yl]-N'-methyl-piperazine-maleates which show interesting psychopharmacologic effects. This work contains the results of a study performed with these three compounds, in order to demonstrate their neuropsycholeptic activity in comparison with chloropromazine (CPZ) and chlordiazepoxide (CPD). The inhibition of motility observed in mice shows that the compounds reduce the normal spontaneous motility as well as the muscle tone. The central-depressant activity is evidenced by increased barbiturate-induced sleep and a remarkable eyelid ptosis can also be observed. Our compounds do not show any activity on electroshock just as do CPZ and CPD. As to the antipsychotic outline, our compounds show strong reduction of lethality due to amphetamine in grouped mice and a strong antiapomorphine activity. They show also an antiaggressive effect and an inhibitory activity on avoidance behaviour much stronger than CPZ. We have also found extrapyramidal effects, as catalepsy, common to many tranquillizers of the kind of the standards used by us. As for vegetative phenomena, the compounds show hypotensive dose related action ranging from moderate to strong, probably due to an a-receptor inhibition. Adrenolytic activity against lethal doses of adrenaline, antiserotonin and antihistaminic effects, as well as other actions (hypothermia, analgesia, etc.) confirm that RMI 61 140, RMI 61 144 and RMI 61 280 are endowed with pharmacologic properties similar and more potent than those of CPZ. Studies on the metabolism of brain catecholamines show that they are similar to CPZ, although with less effect on dopamine level.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Coscia</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Causa</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Giuliani</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nunziata</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Arzneimittelforschung</MedlineTA>
        <NlmUniqueID>0372660</NlmUniqueID>
        <ISSNLinking>0004-4172</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003990">Dibenzoxepins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006634">Histamine H1 Antagonists</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010879">Piperazines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014149">Tranquilizing Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>6RZ6XEZ3CR</RegistryNumber>
          <NameOfSubstance UI="D002707">Chlordiazepoxide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>CK833KGX7E</RegistryNumber>
          <NameOfSubstance UI="D000661">Amphetamine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N21FAR7B4S</RegistryNumber>
          <NameOfSubstance UI="D001058">Apomorphine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>U42B7VYA4P</RegistryNumber>
          <NameOfSubstance UI="D002746">Chlorpromazine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>YKH834O4BH</RegistryNumber>
          <NameOfSubstance UI="D004837">Epinephrine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000374" MajorTopicYN="N">Aggression</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000661" MajorTopicYN="N">Amphetamine</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001058" MajorTopicYN="N">Apomorphine</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001362" MajorTopicYN="N">Avoidance Learning</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002707" MajorTopicYN="N">Chlordiazepoxide</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002746" MajorTopicYN="N">Chlorpromazine</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003990" MajorTopicYN="N">Dibenzoxepins</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004837" MajorTopicYN="N">Epinephrine</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006634" MajorTopicYN="N">Histamine H1 Antagonists</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007928" MajorTopicYN="N">Lethal Dose 50</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009119" MajorTopicYN="N">Muscle Contraction</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012890" MajorTopicYN="N">Sleep</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014149" MajorTopicYN="N">Tranquilizing Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">25</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">26</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>01</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0004-4172</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>25</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Arzneimittel-Forschung</Title>
          <ISOAbbreviation>Arzneimittelforschung</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Studies on the action of an anticholinergic agent in combination with a tranquilizer on gastric juice secretion in man].</ArticleTitle>
        <Pagination>
          <MedlinePgn>1460-3</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>A double-blind study with intra-individual comparisons was carried out to investigate the effects of 15 mg of (8r)-3alpha-hydroxy-8-isopropyl-1alphaH-tropanium bromide(+/-)-tropate (Sch 1000), 15 mg Sch 1000 + 10 mg oxazepam, 10 mg oxazepam and placebo with oral administration in randomized sequence on gastric juice volume, amount of acid, concentration and pH values in 12 healthy volunteers. The secretion parameters were measured during a 1-h basal period and a 2-h stimulation period. The gastric juice was obtained in 15 min portions via stomach tube. Stimulation was effected by 1 mug/kg/h pentagastrin via drip infusion. The Friedman test was used for the comparative statistical evaluation, and individual comparisons were carried out by means of the Wilcoxon test (pair-differences rank). The results show that Sch 1000 and Sch 1000 + oxazepam were equal in effect on basal and stimulated secretion volume. As compared with placebo, it was not possible to establish an effect on secretion volume for oxazepam alone. Sch 1000 and Sch 1000 + oxazepam were found to be equipotent in reducing the amount of basal acid, while oxazepam reduced this quantity only during the first 30 min of basal secretion. None of the three active preparations was capable of inhibiting the stimulated acid, although both Sch 1000 preparations produced a clear trend towards lowered mean values. During the basal secretion period, all three test preparations had an inhibiting action on acid concentration, but none of them had a significant effect during the stimulation period. The pH value was savely increased only by Sch 1000 and Sch 1000 + oxazepam, and this even only during the basal period. The results are discussed.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Scherberger</LastName>
            <ForeName>R R</ForeName>
            <Initials>RR</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaess</LastName>
            <ForeName>H</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brückner</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
          </Author>
        </AuthorList>
        <Language>ger</Language>
        <PublicationTypeList>
          <PublicationType UI="D016430">Clinical Trial</PublicationType>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Untersuchunger über die Wirkung eines Anticholinergikums in Verbindung mit einem Tranquilizer aud die Magensaftsekretion beim Menschen</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Arzneimittelforschung</MedlineTA>
        <NlmUniqueID>0372660</NlmUniqueID>
        <ISSNLinking>0004-4172</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001286">Atropine Derivatives</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>6GOW6DWN2A</RegistryNumber>
          <NameOfSubstance UI="D010076">Oxazepam</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EF0NX91490</RegistryNumber>
          <NameOfSubstance UI="D010418">Pentagastrin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>GR88G0I6UL</RegistryNumber>
          <NameOfSubstance UI="D009241">Ipratropium</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001286" MajorTopicYN="Y">Atropine Derivatives</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003864" MajorTopicYN="N">Depression, Chemical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005750" MajorTopicYN="N">Gastric Juice</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009241" MajorTopicYN="N">Ipratropium</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010076" MajorTopicYN="N">Oxazepam</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010418" MajorTopicYN="N">Pentagastrin</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">26</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0007-0912</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>47</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>British journal of anaesthesia</Title>
          <ISOAbbreviation>Br J Anaesth</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Editorial: "Old lamps for new".</ArticleTitle>
        <Pagination>
          <MedlinePgn>811-2</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Conway</LastName>
            <ForeName>C M</ForeName>
            <Initials>CM</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Anaesth</MedlineTA>
        <NlmUniqueID>0372541</NlmUniqueID>
        <ISSNLinking>0007-0912</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004987">Ethers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>290YE8AR51</RegistryNumber>
          <NameOfSubstance UI="D014241">Trichloroethylene</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>30905R8O7B</RegistryNumber>
          <NameOfSubstance UI="D008733">Methoxyflurane</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>75-89-8</RegistryNumber>
          <NameOfSubstance UI="D014270">Trifluoroethanol</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>91I69L5AY5</RegistryNumber>
          <NameOfSubstance UI="D004737">Enflurane</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>CYS9AKD70P</RegistryNumber>
          <NameOfSubstance UI="D007530">Isoflurane</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>UQT9G45D1P</RegistryNumber>
          <NameOfSubstance UI="D006221">Halothane</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000769" MajorTopicYN="Y">Anesthesia, Inhalation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004737" MajorTopicYN="N">Enflurane</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004987" MajorTopicYN="N">Ethers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006221" MajorTopicYN="N">Halothane</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007530" MajorTopicYN="N">Isoflurane</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007674" MajorTopicYN="N">Kidney Diseases</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008733" MajorTopicYN="N">Methoxyflurane</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014241" MajorTopicYN="N">Trichloroethylene</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014270" MajorTopicYN="N">Trifluoroethanol</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>8</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>8</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>8</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27</ArticleId>
        <ArticleId IdType="pii">S0007-0912(17)47631-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Diabetes Complications. 2000 Mar-Apr;14(2):84-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10959070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Care. 2004 May;27(5):1047-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15111519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Care. 2005 Sep;28(9):2136-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16123479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>East Afr Med J. 2005 Dec;82(12 Suppl):S197-203</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16619733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancet. 2006 May 27;367(9524):1747-57</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16731270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aust Fam Physician. 2006 Jun;35(6):386-90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16751852</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Eng Phys. 2007 Sep;29(7):824-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17052939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Postgrad Med J. 2007 Apr;83(978):224-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17403947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Chem. 2007 Nov;53(11):1954-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17954497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heart. 2008 Nov;94(11):1376-82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18519551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS Med. 2008 Jun 10;5(6):e124</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18547138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancet. 2009 May 23;373(9677):1735</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19465209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ethn Dis. 2009 Spring;19(1 Suppl 1):S1-65-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19484879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Global Health. 2009 Sep 14;5:9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19751503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prim Care Diabetes. 2010 Jul;4(2):69-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20211589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diab Vasc Dis Res. 2010 Jan;7(1):28-39</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20368230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Trop Med Hyg. 2010 Sep;83(3):575-81</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20810823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trop Med Int Health. 2010 Nov;15(11):1289-99</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20955495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trop Med Int Health. 2010 Nov;15(11):1300-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20958887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drug Des Devel Ther. 2010 Oct 22;4:279-90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21116334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trop Med Int Health. 2011 Sep;16(9):1077-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21702868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Med (Lond). 2011 Aug;11(4):344-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21853830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ethn Dis. 2011 Summer;21(3):288-93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21942160</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">28</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0007-0912</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>47</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>British journal of anaesthesia</Title>
          <ISOAbbreviation>Br J Anaesth</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Letter: Duration of action of AH8165.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1033</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Thornton</LastName>
            <ForeName>J A</ForeName>
            <Initials>JA</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harrison</LastName>
            <ForeName>M J</ForeName>
            <Initials>MJ</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Anaesth</MedlineTA>
        <NlmUniqueID>0372541</NlmUniqueID>
        <ISSNLinking>0007-0912</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011726">Pyridinium Compounds</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011726" MajorTopicYN="N">Pyridinium Compounds</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28</ArticleId>
        <ArticleId IdType="doi">10.1093/bja/47.9.1033</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Gen Intern Med. 2002 Aug;17(8):579-87</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12213138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):365-71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18302300</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">29</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2017</Year>
        <Month>03</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0007-0947</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>29</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>The British journal of clinical practice</Title>
          <ISOAbbreviation>Br J Clin Pract</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Lorazepam in sexual disorders.</ArticleTitle>
        <Pagination>
          <MedlinePgn>175-6</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Maneksha</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harry</LastName>
            <ForeName>T V</ForeName>
            <Initials>TV</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016430">Clinical Trial</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Clin Pract</MedlineTA>
        <NlmUniqueID>0372546</NlmUniqueID>
        <ISSNLinking>0007-0947</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014151">Anti-Anxiety Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010919">Placebos</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>O26FZP769L</RegistryNumber>
          <NameOfSubstance UI="D008140">Lorazepam</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014151" MajorTopicYN="N">Anti-Anxiety Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008140" MajorTopicYN="N">Lorazepam</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012735" MajorTopicYN="N">Sexual Dysfunction, Physiological</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>7</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>7</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>7</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">30</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0007-0963</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>93</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>The British journal of dermatology</Title>
          <ISOAbbreviation>Br J Dermatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Lysosomal hydrolases of the epidermis. I. Glycosidases.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1-10</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Seven distinct glycosidases (EC 3.2) have been characterized in guinea-pig epidermis. Their properties indicate them to be of lysosomal origin. The 'profile' of the epidermal glycosidases is significantly different from that reported for whole skin, the activities of beta-galactosidase and beta-acetylglucosaminidase being very high and those of the remaining enzymes relatively low in epidermis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mier</LastName>
            <ForeName>P D</ForeName>
            <Initials>PD</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>van den Hurk</LastName>
            <ForeName>J J</ForeName>
            <Initials>JJ</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>MC_UP_A620_1017</GrantID>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Dermatol</MedlineTA>
        <NlmUniqueID>0004041</NlmUniqueID>
        <ISSNLinking>0007-0963</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 3.2.1.-</RegistryNumber>
          <NameOfSubstance UI="D005696">Galactosidases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.2.1.-</RegistryNumber>
          <NameOfSubstance UI="D006026">Glycoside Hydrolases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.2.1.52</RegistryNumber>
          <NameOfSubstance UI="D000118">Acetylglucosaminidase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000118" MajorTopicYN="N">Acetylglucosaminidase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005696" MajorTopicYN="N">Galactosidases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006026" MajorTopicYN="N">Glycoside Hydrolases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>7</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>7</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>7</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30</ArticleId>
        <ArticleId IdType="doi">10.1111/j.1365-2133.1975.tb06468.x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>JAMA. 2004 Oct 13;292(14):1724-37</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15479938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obes Surg. 2005 Feb;15(2):266-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15802072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obes Rev. 2007 Mar;8 Suppl 1:vi-ix</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17316292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obes Rev. 2007 Mar;8 Suppl 1:161-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17316321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Public Health. 2007 Jul;121(7):492-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17399752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Obes. 2011 Apr;1(2-3):77-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25585572</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0007-0963</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>93</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Oct</Month>
            </PubDate>
          </JournalIssue>
          <Title>The British journal of dermatology</Title>
          <ISOAbbreviation>Br J Dermatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Lysosomal hydrolases of the epidermis. 2. Ester hydrolases.</ArticleTitle>
        <Pagination>
          <MedlinePgn>391-8</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Five distinct ester hydrolases (EC 3-1) have been characterized in guinea-pig epidermis. These are carboxylic esterase, acid phosphatase, pyrophosphatase, and arylsulphatase A and B. Their properties are consistent with those of lysosomal enzymes.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mier</LastName>
            <ForeName>P D</ForeName>
            <Initials>PD</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>van den Hurk</LastName>
            <ForeName>J J</ForeName>
            <Initials>JJ</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Dermatol</MedlineTA>
        <NlmUniqueID>0004041</NlmUniqueID>
        <ISSNLinking>0007-0963</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 3.-</RegistryNumber>
          <NameOfSubstance UI="D006867">Hydrolases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.1.-</RegistryNumber>
          <NameOfSubstance UI="D002265">Carboxylic Ester Hydrolases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.3.2</RegistryNumber>
          <NameOfSubstance UI="D000135">Acid Phosphatase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.6.8</RegistryNumber>
          <NameOfSubstance UI="D002553">Cerebroside-Sulfatase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.6.9</RegistryNumber>
          <NameOfSubstance UI="D002803">Chondro-4-Sulfatase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.6.1.-</RegistryNumber>
          <NameOfSubstance UI="D011755">Pyrophosphatases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000135" MajorTopicYN="N">Acid Phosphatase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002265" MajorTopicYN="N">Carboxylic Ester Hydrolases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002553" MajorTopicYN="N">Cerebroside-Sulfatase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002803" MajorTopicYN="N">Chondro-4-Sulfatase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006867" MajorTopicYN="N">Hydrolases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011755" MajorTopicYN="N">Pyrophosphatases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>10</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31</ArticleId>
        <ArticleId IdType="doi">10.1111/j.1365-2133.1975.tb06512.x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Healthc Manag. 2006 Sep-Oct;51(5):309-20; discussion 320-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17039690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Med (Lond). 2010 Feb;10(1):13-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20408298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Med (Lond). 2010 Oct;10(5):441-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21117373</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0007-1048</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>29</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>British journal of haematology</Title>
          <ISOAbbreviation>Br J Haematol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A serum haemagglutinating property dependent upon polycarboxyl groups.</ArticleTitle>
        <Pagination>
          <MedlinePgn>149-56</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>A serum agglutinin reactive with red cells in the presence of polycarboxyl groups is reported. It is likely that this represents an additional example of the type of agglutinin previously described as agglutinating red cells in the absence of ionized calcium. Experimental evidence is presented indicating that it is free polycarboxyl groups that potentiate agglutination and that any metal ion, such as calcium, capable of chelating with these groups will prove to be inhibitory.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Beck</LastName>
            <ForeName>M L</ForeName>
            <Initials>ML</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Freihaut</LastName>
            <ForeName>B</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Henry</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pierce</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bayer</LastName>
            <ForeName>W L</ForeName>
            <Initials>WL</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Haematol</MedlineTA>
        <NlmUniqueID>0372544</NlmUniqueID>
        <ISSNLinking>0007-1048</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000017">ABO Blood-Group System</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000373">Agglutinins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002264">Carboxylic Acids</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002413">Cations, Divalent</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002951">Citrates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9G34HU7RV0</RegistryNumber>
          <NameOfSubstance UI="D004492">Edetic Acid</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.2.1.18</RegistryNumber>
          <NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.22.2</RegistryNumber>
          <NameOfSubstance UI="D010206">Papain</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.22.3</RegistryNumber>
          <NameOfSubstance UI="D005361">Ficain</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000017" MajorTopicYN="N">ABO Blood-Group System</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000373" MajorTopicYN="N">Agglutinins</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000918" MajorTopicYN="N">Antibody Specificity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002264" MajorTopicYN="N">Carboxylic Acids</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002413" MajorTopicYN="N">Cations, Divalent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002951" MajorTopicYN="N">Citrates</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004492" MajorTopicYN="N">Edetic Acid</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005361" MajorTopicYN="N">Ficain</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006384" MajorTopicYN="N">Hemagglutination</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010206" MajorTopicYN="N">Papain</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>1</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>1</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32</ArticleId>
        <ArticleId IdType="doi">10.1111/j.1365-2141.1975.tb01808.x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Reg Anesth Pain Med. 2000 Jul-Aug;25(4):393-402</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10925937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anesth Analg. 2000 Oct;91(4):916-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11004048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neurology. 2005 Aug 23;65(4):510-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16116106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neurologist. 2006 Jul;12(4):224-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16832241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JAMA. 2006 Oct 25;296(16):2012-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17062865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Postgrad Med J. 2006 Nov;82(973):713-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17099089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Intern Med J. 2008 Jul;38(7):587-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18422562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Headache. 2010 Oct;50(9):1482-98</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20807248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anesthesiol Res Pract. 2010;2010:null</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20814596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anaesth Intensive Care. 2011 Mar;39(2):247-51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21485674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neurology. 2011 Jul 5;77(1):71-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21593442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CMAJ. 1993 Oct 15;149(8):1087-93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8221447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 1993 Apr 3;306(6882):883-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8490410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reg Anesth. 1997 Jan-Feb;22(1):66-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9010949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurol. 1998 Sep;245(9):589-92</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9758296</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>07</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0007-1048</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>29</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>British journal of haematology</Title>
          <ISOAbbreviation>Br J Haematol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effect of human erythrocyte stromata on complement activation.</ArticleTitle>
        <Pagination>
          <MedlinePgn>235-41</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Stroma from either normal or PNH-like red cells is capable of inhibiting, to some extent, lysis in the sucrose test and enhancing lysis in the acidified-serum test. The same opposing effects are displayed by the exclusion peaks from Sephadex G-200 obtained from each stroma preparation, suggesting that the same factor could be responsible for both activities. Stromata and peaks also induce lysis of PNH-like cells in unacidified serum, indicating activation of complement through the alternate pathway. This is confirmed by immunoelectrophoretic observation. When serum previously activated through the alternate pathway is used in the sucrose test the amount of lysis is markedly reduced. This would indicate that the classical pathway activation can be controlled by the alternate pathway. The possible clinical significance of these factors in determining the haemolytic crisis in PNH patients is discussed.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Corrocher</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tedesco</LastName>
            <ForeName>F</ForeName>
            <Initials>F</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rabusin</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Sandre</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Haematol</MedlineTA>
        <NlmUniqueID>0372544</NlmUniqueID>
        <ISSNLinking>0007-1048</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>57-50-1</RegistryNumber>
          <NameOfSubstance UI="D013395">Sucrose</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9007-36-7</RegistryNumber>
          <NameOfSubstance UI="D003165">Complement System Proteins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003165" MajorTopicYN="N">Complement System Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006457" MajorTopicYN="N">Hemoglobinuria, Paroxysmal</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006461" MajorTopicYN="Y">Hemolysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013395" MajorTopicYN="N">Sucrose</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>2</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33</ArticleId>
        <ArticleId IdType="doi">10.1111/j.1365-2141.1975.tb01817.x</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0007-1048</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>29</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>British journal of haematology</Title>
          <ISOAbbreviation>Br J Haematol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Determinants of intracellular pH in the erythrocyte.</ArticleTitle>
        <Pagination>
          <MedlinePgn>369-72</MedlinePgn>
        </Pagination>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Warth</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Desforges</LastName>
            <ForeName>J F</ForeName>
            <Initials>JF</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Haematol</MedlineTA>
        <NlmUniqueID>0372544</NlmUniqueID>
        <ISSNLinking>0007-1048</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004163">Diphosphoglyceric Acids</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002463" MajorTopicYN="N">Cell Membrane Permeability</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004163" MajorTopicYN="N">Diphosphoglyceric Acids</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004912" MajorTopicYN="Y">Erythrocytes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="Y">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008564" MajorTopicYN="N">Membrane Potentials</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <NumberOfReferences>18</NumberOfReferences>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>3</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34</ArticleId>
        <ArticleId IdType="doi">10.1111/j.1365-2141.1975.tb01833.x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Pacing Clin Electrophysiol. 1999 May;22(5):711-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10353129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Cardiol. 2003 Sep 15;92(6):740-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12972124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World J Surg. 2004 Mar;28(3):321-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14961191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heart. 2005 Apr;91(4):500-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15772212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Circulation. 2007 Sep 18;116(12):1349-55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17724263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur Heart J. 2011 Apr;32(8):991-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21252172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Coll Cardiol. 2012 Oct 16;60(16):1540-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22999727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br Heart J. 1987 Nov;58(5):537-46</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3676046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br Heart J. 1995 Jun;73(6):571-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7626359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pacing Clin Electrophysiol. 1994 Nov;17(11 Pt 2):2012-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7845809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br Heart J. 1994 Sep;72(3):303-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7946793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Interv Card Electrophysiol. 1998 Jun;2(2):175-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9870010</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>07</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0007-1048</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>30</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>British journal of haematology</Title>
          <ISOAbbreviation>Br J Haematol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The effect of o-salicylate upon pentose phosphate pathway activity in normal and G6PD-deficient red cells.</ArticleTitle>
        <Pagination>
          <MedlinePgn>225-31</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>The effect of the major metabolite of aspirin, namely salicylic acid, upon the pentose phosphate pathway (PPP) of normal and G6PD-deficient red cells has been studied. Salicylic acid was shown to inhibit this pathway in proportion to the amount present. At any concentration of this substance there was greater inhibition of the PPP in G6PD-deficient than in normal red cells.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Worathumrong</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grimes</LastName>
            <ForeName>A J</ForeName>
            <Initials>AJ</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Haematol</MedlineTA>
        <NlmUniqueID>0372544</NlmUniqueID>
        <ISSNLinking>0007-1048</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010428">Pentosephosphates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>T42P99266K</RegistryNumber>
          <NameOfSubstance UI="D008751">Methylene Blue</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>WIQ1H85SYP</RegistryNumber>
          <NameOfSubstance UI="D012980">Sodium Salicylate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005955" MajorTopicYN="N">Glucosephosphate Dehydrogenase Deficiency</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008751" MajorTopicYN="N">Methylene Blue</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010428" MajorTopicYN="N">Pentosephosphates</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012980" MajorTopicYN="N">Sodium Salicylate</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>6</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>6</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35</ArticleId>
        <ArticleId IdType="doi">10.1111/j.1365-2141.1975.tb00536.x</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">36</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>07</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0007-1145</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>34</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>The British journal of nutrition</Title>
          <ISOAbbreviation>Br J Nutr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The effects of processing of barley-based supplements on rumen pH, rate of digestion of voluntary intake of dried grass in sheep.</ArticleTitle>
        <Pagination>
          <MedlinePgn>493-500</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>1. In one experiment the effect on rumen pH of feeding with restricted amounts of whole or pelleted barley was studied. With whole barley there was little variation in rumen pH associated with feeding time, but with pelleted barley the pH decreased from about 7-0 before feeding to about 5-3, 2--3 h after feeding. 2. The rate of disappearance of dried grass during incubation in the rumens of sheep receiving either whole or pelleted barley was studied in a second experiment. After 24 h incubation only 423 mg/g incubated had disappeared in the rumen of sheep receiving pelleted barley while 625 mg/g incubated had disappeared when it was incubated in the rumen of sheep receiving whole barley. 3. The voluntary intake of dried grass of lambs was studied in a third experiment when they received supplements of either 25 or 50 g whole or pelleted barley/kg live weight 0-75. At the high level, pelleted barley reduced intake of dried grass by 534 g/kg but whole barley reduced it by only 352 g/kg. The digestibility of acid-detergent fibre was reduced more by pelleted barley than by whole barley but there was a tendency for a small increase in digestibility of the barley due to processing. 4. The implications of these findings on supplementation of roughages with cereals are discussed.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Orskov</LastName>
            <ForeName>E R</ForeName>
            <Initials>ER</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fraser</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Nutr</MedlineTA>
        <NlmUniqueID>0372547</NlmUniqueID>
        <ISSNLinking>0007-1145</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000821" MajorTopicYN="Y">Animal Feed</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004063" MajorTopicYN="Y">Digestion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002523" MajorTopicYN="Y">Edible Grain</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005750" MajorTopicYN="N">Gastric Juice</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001467" MajorTopicYN="Y">Hordeum</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="Y">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012417" MajorTopicYN="Y">Rumen</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012756" MajorTopicYN="Y">Sheep</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">36</ArticleId>
        <ArticleId IdType="doi">10.1017/s0007114575000530</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">37</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>23</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Nov</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Poly(8-aminoguanylic acid): formation of ordered self-structures and interaction with poly(cytidylic acid).</ArticleTitle>
        <Pagination>
          <MedlinePgn>5033-45</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Poly(8-aminoguanylic acid) has in neutral solution a novel ordered structure of high stability. The 8-amino group permits formation of three hydrogen bonds between two residues along the "top", or long axis, of the purines. The usual hydrogen bonding protons and Watson-Crick pairing sites are not involved in the association. The bonding scheme has a twofold rotation axis and is hemiprotonated at N(7). Poly(8NH2G) is converted by alkaline titration (pK = 9.7) to a quite different ordered structure, which is the favored form over the range approximately pH 10-11. The bonding scheme appears to be composed of a planar, tetrameric array of guanine residues, in which the 8-amino group does not participate in interbase hydrogen bonding. Poly (8NH2G) does not interact with poly(C) in neutral solution because of the high stability of the hemiprotonated G-G self-structure. Titration to the alkaline plateau, however, permits ready formation of a two-stranded Watson-Crick helix. In contrast to the monomer 8NH2GMP, poly(8NH2G) does not form a triple helix with poly(C) under any conditions. The properties of the ordered structures are interpreted in terms of a strong tendency of the 8-amino group to form a third interbase hydrogen bond, when this possibility is not prevented by high pH.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hattori</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Frazier</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miles</LastName>
            <ForeName>H T</ForeName>
            <Initials>HT</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011131">Polyribonucleotides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>25191-14-4</RegistryNumber>
          <NameOfSubstance UI="D011068">Poly G</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>30811-80-4</RegistryNumber>
          <NameOfSubstance UI="D011066">Poly C</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.7.8</RegistryNumber>
          <NameOfSubstance UI="D011117">Polyribonucleotide Nucleotidyltransferase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002942" MajorTopicYN="N">Circular Dichroism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004355" MajorTopicYN="N">Drug Stability</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006860" MajorTopicYN="N">Hydrogen Bonding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008837" MajorTopicYN="N">Micrococcus</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009690" MajorTopicYN="N">Nucleic Acid Conformation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011066" MajorTopicYN="Y">Poly C</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011068" MajorTopicYN="N">Poly G</DescriptorName>
          <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011117" MajorTopicYN="N">Polyribonucleotide Nucleotidyltransferase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011131" MajorTopicYN="Y">Polyribonucleotides</DescriptorName>
          <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013055" MajorTopicYN="N">Spectrophotometry, Infrared</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013056" MajorTopicYN="N">Spectrophotometry, Ultraviolet</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">37</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00694a002</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Arch Intern Med. 2003 Apr 14;163(7):803-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12695271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Postgrad Med J. 2004 Feb;80(940):104-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14970300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surg Endosc. 2005 Oct;19(10):1349-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16021375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Radiol. 2006 Feb;61(2):127-39</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16439217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surg Endosc. 2006 Jul;20(7):1147-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16763922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Age Ageing. 2007 Jan;36(1):48-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17114203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Gastroenterol. 2009 May-Jun;43(5):448-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18978506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Intern Med. 2009 Jun 16;150(12):849-57, W152</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19528563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>AJR Am J Roentgenol. 2010 May;194(5):1279-87</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20410415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Best Pract Res Clin Gastroenterol. 2010 Jun;24(3):271-80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20510828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Radiol. 1993 Jul;48(1):48-51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8370220</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">38</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>23</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Nov</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effect of pH on substrate and inhibitor kinetic constants of human liver alanine aminopeptidase. Evidence for two ionizable active center groups.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5084-8</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>The presence of at least two ionizable active center groups has been detected by a study of the effect of pH upon catalysis of hydrolysis of L-alanyl-beta-naphthylamide by human liver alanine aminopeptidase and upon the inhibition of hydrolysis by inhibitors and substrate analogs. Octanoic acid, octylamine, and peptide inhibitors have been found to be competitive inhibitors and are therefore thought to bind the active center. L-Phe was previously shown to bind the active center since it was found to be a competitive inhibitor of the hydrolysis of tripeptide substrates (Garner, C. W., and Behal, F. J. (1975), Biochemistry 14, 3208). A plot of pKm vs. pH for the substrate L-Ala-beta-naphthylamide showed that binding decreased below pH 5.9 and above 7.5, the points at which the theoretical curve undergoes an integral change in slope. These points are interpreted as the pKa either of substrate ionizable groups or binding-dependent enzyme active center groups. Similar plots of pKm vs. pH for L-alanyl-p-nitroanilide (as substrate) and pKi vs. pH for L-Leu-L-Leu-L-Leu and D-Leu-L-Tyr (as inhibitors) gave pairs fo pKa values of 5.8 and 7.4, 6.0 and 7.5, and 5.7 and 7.5, respectively. All the above substrates (and D-Leu-L-Tyr) have pKa values near 7.5; therefore, the binding-dependent group with a pKa value near 7.5 is possibly this substrate group. Similar plots of pKi vs. pH for the inhibitors L-Phe, L-Met, L-Leu, octylamine, and octanoic acid had only one bending point at 7.7, 7.6, 7.4, 6.3, and 5.9, respectively. Amino acid inhibitors, octylamine, and octanoic acid have no groups with pKa values between 5 and 9. These data indicate that there are two active center ionizable groups with pKa values of approximately 6.0 and 7.5 which are involved in substrate binding or inhibitory amino acid binding but not in catalysis since Vmax was constant at all pH values tested.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Garner</LastName>
            <ForeName>C W</ForeName>
            <Initials>CW</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Behal</LastName>
            <ForeName>F J</ForeName>
            <Initials>FJ</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 3.4.11.-</RegistryNumber>
          <NameOfSubstance UI="D000626">Aminopeptidases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>OF5P57N2ZX</RegistryNumber>
          <NameOfSubstance UI="D000409">Alanine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000626" MajorTopicYN="N">Aminopeptidases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008433" MajorTopicYN="N">Mathematics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013816" MajorTopicYN="N">Thermodynamics</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">38</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00694a009</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Postgrad Med J. 1994 Oct;70(828):728-31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7831169</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">39</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>23</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Nov</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Formation of transient complexes in the glutamate dehydrogenase catalyzed reaction.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5094-8</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>The reaction of glutamate dehydrogenase and glutamate (gl) with NAD+ and NADP+ has been studied with stopped-flow techniques. The enzyme was in all experiments present in excess of the coenzyme. The results indicate that the ternary complex (E-NAD(P)H-kg) is present as an intermediate in the formation of the stable complex (E-NAD(P)H-gl). The identification of the complexes is based on their absorption spectra. The binding of the coenzyme to (E-gl) is the rate-limiting step in the formation of (E-NAD(P)H-kg) while the dissociation of alpha-ketoglutarate (kg) from this complex is the rate-limiting step in the formation of (E-NAD(P)H-gl). The Km for glutamate was 20-25 mM in the first reaction and 3 mM in the formation of the stable complex. The Km values were independent of the coenzyme. The reaction rates with NAD+ were approximately 50% greater than those with NADP+. Furthermore, high glutamate concentration inhibited the formation of (E-NADH-kg) while no substrate inhibition was found with NADP+ as coenzyme. ADP enhanced while GTP reduced the rate of (E-NAD(P)H-gl) formation. The rate of formation of (E-NAD(P)H-kg) was inhibited by ADP, while it increased at high glutamate concentration when small amounts of GTP were added. The results show that the higher activity found with NAD+ compared to NADP+ under steady-state assay conditions do not necessarily involve binding of NAD+ to the ADP activating site of the enzyme. Moreover, the substrate inhibition found at high glutamate concentration under steady-state assay condition is not due to the formation of (E-NAD(P)H-gl) as this complex is formed with Km of 3 mM glutamate, and the substrate inhibition is only significant at 20-30 times this concentration.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sanner</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005971">Glutamates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0U46U6E8UK</RegistryNumber>
          <NameOfSubstance UI="D009243">NAD</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>53-59-8</RegistryNumber>
          <NameOfSubstance UI="D009249">NADP</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>61D2G4IYVH</RegistryNumber>
          <NameOfSubstance UI="D000244">Adenosine Diphosphate</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>86-01-1</RegistryNumber>
          <NameOfSubstance UI="D006160">Guanosine Triphosphate</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.4.1.2</RegistryNumber>
          <NameOfSubstance UI="D005969">Glutamate Dehydrogenase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000244" MajorTopicYN="N">Adenosine Diphosphate</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005969" MajorTopicYN="N">Glutamate Dehydrogenase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005971" MajorTopicYN="N">Glutamates</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006160" MajorTopicYN="N">Guanosine Triphosphate</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009243" MajorTopicYN="N">NAD</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009249" MajorTopicYN="N">NADP</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013056" MajorTopicYN="N">Spectrophotometry, Ultraviolet</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">39</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00694a011</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Nature. 2000 May 25;405(6785):417</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10839527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastroenterology. 2000 Aug;119(2):300-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10930364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gut. 2003 Jun;52 Suppl 4:iv17-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12746264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gut. 2004 Feb;53(2):277-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14724164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastrointest Endosc Clin N Am. 2004 Jan;14(1):1-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15062374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastrointest Endosc Clin N Am. 2004 Jan;14(1):43-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15062379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JAMA. 2004 Apr 14;291(14):1713-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15082698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endoscopy. 2004 Jul;36(7):656-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15243892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gut. 2004 Dec;53(12):1866-75</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15542530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aliment Pharmacol Ther. 2004 Nov 15;20(10):1083-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15569110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Intern Med. 2005 Apr 19;142(8):635-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15838071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aliment Pharmacol Ther. 2005 Oct 1;22(7):595-604</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16181299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endoscopy. 2005 Oct;37(10):960-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16189768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastrointest Endosc. 2005 Nov;62(5):785-90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16246700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Gastroenterol. 2005 Nov;100(11):2407-18</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16279893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endoscopy. 2006 Jan;38(1):31-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16429352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endoscopy. 2006 Jan;38(1):59-66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16429356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastrointest Endosc. 2006 Apr;63(4):539-45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16564850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endoscopy. 2006 Oct;38(10):963-70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17058158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endoscopy. 2006 Oct;38(10):971-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17058159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endoscopy. 2006 Oct;38(10):1047-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17058174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastrointest Endosc. 2007 Apr;65(4):577-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17324414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dig Dis Sci. 2007 May;52(5):1382-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17357836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dig Liver Dis. 2007 Oct;39(10):895-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17720639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trials. 2007 Oct 27;8:32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17963520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2007 Nov 29;357(22):2277-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18046031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2007 Dec 8;335(7631):1182-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18063642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gut. 2008 Jan;57(1):125-36</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18094205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radiology. 1981 Jul;140(1):47-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7244242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>AJR Am J Roentgenol. 1994 Dec;163(6):1381-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7992733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastrointest Endosc Clin N Am. 1999 Jan;9(1):13-27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9834314</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">40</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>23</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Nov</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Human brain and placental choline acetyltransferase: purification and properties.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5105-10</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Choline acetyltransferase (EC 2.3.1.6) catalyzes the biosynthesis of acetylcholine according to the following chemical equation: acetyl-CoA + choline in equilibrium to acetylcholine + CoA. In addition to nervous tissue, primate placenta is the only other animal source which contains appreciable acetylcholine and its biosynthetic enzyme. Human brain caudate nucleus and human placental choline acetyltransferase were purified to electrophoretic homogeneity using ion-exchange and blue dextran-Sepharose affinity chromatography. The molecular weights determined by Sephadex G-150 gel filtration and sodium dodecyl sulfate gel electrophoresis are 67000 plus or minus 3000. N-Ethylmaleimide, p-chloromercuribenzoate, and dithiobis(2-nitrobenzoic acid) inhibit the enzyme. Dithiothreitol reverses the inhibition produced by the latter two reagents. The pKa of the group associated with N-ethylmaleimide inhibition is 8.6 plus or minus 0.3. A chemically competent acetyl-thioenzyme is isolable by Sephadex gel filtration. The enzymes from the brain and placenta are thus far physically and biochemically indistinguishable.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Roskoski</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
            <Suffix>Jr</Suffix>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lim</LastName>
            <ForeName>C T</ForeName>
            <Initials>CT</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roskoski</LastName>
            <ForeName>L M</ForeName>
            <Initials>LM</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013439">Sulfhydryl Reagents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.1.-</RegistryNumber>
          <NameOfSubstance UI="D000123">Acetyltransferases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.1.6</RegistryNumber>
          <NameOfSubstance UI="D002795">Choline O-Acetyltransferase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>O3C74ACM9V</RegistryNumber>
          <NameOfSubstance UI="D005033">Ethylmaleimide</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000123" MajorTopicYN="N">Acetyltransferases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002421" MajorTopicYN="N">Caudate Nucleus</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002795" MajorTopicYN="N">Choline O-Acetyltransferase</DescriptorName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005033" MajorTopicYN="N">Ethylmaleimide</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010920" MajorTopicYN="N">Placenta</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013439" MajorTopicYN="N">Sulfhydryl Reagents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2001</Year>
          <Month>3</Month>
          <Day>28</Day>
          <Hour>10</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">40</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00694a013</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lancet. 1999 Jul 17;354(9174):191-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10421300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Rehabil Med. 2001 Jan;33(1):47-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11480471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Disabil Rehabil. 2001 Oct 15;23(15):670-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11720117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Rehabil. 2002 Mar;16(2):182-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11926176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Rehabil. 2002 May;16(3):231-47</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12017511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Psychiatr Res. 1975 Nov;12(3):189-98</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1202204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancet. 2002 Jun 22;359(9324):2205</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12091014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Epidemiol. 2002 Sep;55(9):922-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12393081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Rehabil Med. 2002 Nov;34(6):260-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12440799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Md State Med J. 1965 Feb;14:61-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14258950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Disabil Rehabil. 2004 Jan 21;26(2):71-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14668142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neurology. 2004 May 25;62(10):1842-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15159490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurol Neurosurg Psychiatry. 2006 May;77(5):634-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16614023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neuroepidemiology. 2009;33(3):254-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19641331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Epidemiol. 1989;42(8):703-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2760661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Disabil Stud. 1988;10(2):61-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3403500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stroke. 1998 Apr;29(4):779-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9550511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Rehabil. 1998 Aug;12(4):304-18</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9744666</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">41</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>23</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Nov</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Stabilization of the globular structure of ferricytochrome c by chloride in acidic solvents.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5135-40</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Increasing concentrations of chloride were found to increase the resolution between two visible absorbance spectral transitions associated with acidification of ferricytochrome c. Analysis of a variety of spectral and viscosity measurements indicates that protonation of a single group having an apparent pK of 2.1 +/- 0.2 and an intrinsic pK of about 5.3 displaces the methionine ligand without significantly perturbing the native globular conformation. Analysis of methylated ferricytochrome c suggests that protonation of a carboxylate ion, most likely a heme propionate residue, is responsible for displacement of the methionine ligand. Addition of a proton to a second group having an apparent pK of 1.2 +/- 0.1 displaces the histidine ligand and unfolds the protein from a globular conformation into a random coil. It is most likely that the second protonation occurs on the imidazole ring of the histidine ligand itself. Chloride is proposed to perturb these transitions by ligation in the fifth coordination position of the heme ion. Such ligation stabilizes a globular conformation of ferricytochrome c at pH 0.0 and 25 degrees.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stellwagen</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Babul</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002712">Chlorides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003574">Cytochrome c Group</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012997">Solvents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002712" MajorTopicYN="N">Chlorides</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003574" MajorTopicYN="Y">Cytochrome c Group</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006736" MajorTopicYN="N">Horses</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008433" MajorTopicYN="N">Mathematics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012997" MajorTopicYN="N">Solvents</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013053" MajorTopicYN="N">Spectrophotometry</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014783" MajorTopicYN="N">Viscosity</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">41</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00694a018</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">42</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>23</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Nov</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A competitive labeling method for the determination of the chemical properties of solitary functional groups in proteins.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5168-75</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>The properties of the functional groups in a protein can be used as built-in-probes of the structure of the protein. We have developed a general procedure whereby the ionization constant and chemical reactivity of solitary functional groups in proteins may be determined. The method may be applied to the side chain of histidine, tyrosine, lysine, and cysteine, as well as to the amino terminus of the protein. The method, which is an extension of the competitive labeling technique using [3H]- and [14C]1-fluoro-2,4-dinitrobenzene (N2ph-F) in a double-labeling procedure, is rapid and sensitive. Advantage is taken of the fact that after acid hydrolysis of a dinitrophenylated protein, a derivative is obtained which must be derived from a unique position in the protein. The method has been applied to the solitary histidine residue of lysozyme, alpha-lytic protease, and Streptomyces griseus (S.G.) trypsin, as well as to the amino terminus of the latter protein. The following parameters were obtained for reaction with N2ph-F at 20 degrees C in 0.1 N KCl: the histidine of hen egg-white lysozyme, pKa of 6.4 and second-order velocity constant of 0.188 M-1 min-1; the histidine of alpha-lytic protease, pKa of 6.5 and second-order velocity constant of 0.0235 M-1 min-1; the histidine of S.G. trypsin, pKa of 6.5 and second-order velocity constant of 0.0328 M-1 min-1; the valyl amino terminus of S.G. trypsin, pKa of 8.1 and second-order velocity constant of 0.403 M-1 min-1. In addition, the results obtained provide clues as to the microenvironments of these functional groups, and indicate that the proteins studied undergo pH-dependent conformational changes which affect the microenvironment, and hence the chemical reactivity of these groups.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Duggleby</LastName>
            <ForeName>R G</ForeName>
            <Initials>RG</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kaplan</LastName>
            <ForeName>H</ForeName>
            <Initials>H</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>4QD397987E</RegistryNumber>
          <NameOfSubstance UI="D006639">Histidine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>D241E059U6</RegistryNumber>
          <NameOfSubstance UI="D004139">Dinitrofluorobenzene</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.2.1.17</RegistryNumber>
          <NameOfSubstance UI="D009113">Muramidase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.-</RegistryNumber>
          <NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.21.4</RegistryNumber>
          <NameOfSubstance UI="D014357">Trypsin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>HG18B9YRS7</RegistryNumber>
          <NameOfSubstance UI="D014633">Valine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001667" MajorTopicYN="N">Binding, Competitive</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004139" MajorTopicYN="N">Dinitrofluorobenzene</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006639" MajorTopicYN="N">Histidine</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009113" MajorTopicYN="N">Muramidase</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013305" MajorTopicYN="N">Streptomyces griseus</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014357" MajorTopicYN="N">Trypsin</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014633" MajorTopicYN="N">Valine</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">42</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00694a023</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">43</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>23</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Nov</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Modification of arginine and lysine in proteins with 2,4-pentanedione.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5194-9</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Primary amines react with 2,4-pentanedione at pH 6-9 to form enamines, N-alkyl-4-amino-3-penten-2-ones. The latter compounds readily regenerate the primary amine at low pH or on treatment with hydroxylamine. Guanidine and substituted guanidines react with 2,4-pentanedione to form N-substituted 2-amino-4,6-dimethylpyrimidines at a rate which is lower by at least a factor of 20 than the rate of reaction of 2,4-pentanedione with primary amines. Selective modification of lysine and arginine side chains in proteins can readily be achieved with 2,4-pentanedione. Modification of lysine is favored by reaction at pH 7 or for short reaction times at pH 9. Selective modification of arginine is achieved by reaction with 2,4-pentanedione for long times at pH 9, followed by treatment of the protein with hydroxylamine. The extent of modification of lysine and arginine side chains can readily be measured spectrophotometrically. Modification of lysozyme with 2,4-pentanedione at pH 7 results in modification of 3.8 lysine residues and less than 0.4 arginine residue in 24 hr. Modification of lysozyme with 2,4-pentanedione at pH 9 results in modification of 4 lysine residues and 4.5 arginine residues in 100 hr. Treatment of this modified protein with hydroxylamine regenerated the modified lysine residues but caused no change in the modified arginine residues. One arginine residue seems to be essential for the catalytic activity of the enzyme.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gilbert</LastName>
            <ForeName>H F</ForeName>
            <Initials>HF</Initials>
            <Suffix>3rd</Suffix>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Leary</LastName>
            <ForeName>M H</ForeName>
            <Initials>MH</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007659">Ketones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010422">Pentanones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>94ZLA3W45F</RegistryNumber>
          <NameOfSubstance UI="D001120">Arginine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.2.1.17</RegistryNumber>
          <NameOfSubstance UI="D009113">Muramidase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>K3Z4F929H6</RegistryNumber>
          <NameOfSubstance UI="D008239">Lysine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001120" MajorTopicYN="Y">Arginine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007659" MajorTopicYN="Y">Ketones</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008239" MajorTopicYN="Y">Lysine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008837" MajorTopicYN="N">Micrococcus</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009113" MajorTopicYN="N">Muramidase</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010422" MajorTopicYN="Y">Pentanones</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011506" MajorTopicYN="Y">Proteins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013056" MajorTopicYN="N">Spectrophotometry, Ultraviolet</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">43</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00694a027</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">44</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>24</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Dec</Month>
              <Day>02</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The origin of the alkaline inactivation of pepsinogen.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5253-6</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Above pH 8.5, pepsinogen is converted into a form which cannot be activated to pepsin on exposure to low pH. Intermediate exposure to neutral pH, however, returns the protein to a form which can be activated. Evidence is presented for a reversible, small conformational change in the molecule, distinct from the unfolding of the protein. At the same time, the molecule is converted to a form of limited solubility, which is precipitated at low pH, where activation is normally seen. The results are interpreted in terms of the peculiar structure of the pepsinogen molecule. Titration of the basic NH2-terminal region produced an open form, which can return to the native form at neutral pH, but which is maintained at low pH by neutralization of carboxylate groups in the pepsin portion.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>McPhie</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010435">Pepsinogens</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.23.1</RegistryNumber>
          <NameOfSubstance UI="D010434">Pepsin A</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010434" MajorTopicYN="N">Pepsin A</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010435" MajorTopicYN="N">Pepsinogens</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013056" MajorTopicYN="N">Spectrophotometry, Ultraviolet</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">44</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00695a003</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">45</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>24</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Dec</Month>
              <Day>02</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Bovine liver dihydrofolate reductase: purification and properties of the enzyme.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5261-7</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>A purification procedure is reported for obtaining bovine liver dihydrofolate reductase in high yield and amounts of 100-200 mg. A key step in the procedure is the use of an affinity gel prepared by coupling pteroyl-L-lysine to Sepharose. The purified reductase has a specific activity of about 100 units/mg and is homogeneous as judged by analytical ultracentrifugation, polyacrylamide gel electrophoresis, and titration with methotrexate. The products of the first step of Edman degradation indicated a minimum purity of 79%. The reductase has a molecular weight of about 21500 on the basis of amino acid composition and 22100 +/- 300 from equilibrium sedimentation. It is not inhibited by antiserum to the Streptococcus faecium reductase (isoenzyme 2). Unlike the reductase of many other vertebrate tissues, the bovine enzyme is inhibited by mercurials rather than activated and it has a single pH optimum at both low and high ionic strength. However, the position of the pH optimum is shifted and the activity increased by increasing ionic strength. Automatic Edman degradation has been used to determine 34 of the amino-terminal 37 amino acid residues. Considerable homology exists between this region and the corresponding regions of the reductase from S. faecium and from Escherichia coli. This strengthens the idea that this region contributes to the structure of the binding site for dihydrofolate.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Peterson</LastName>
            <ForeName>D L</ForeName>
            <Initials>DL</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gleisner</LastName>
            <ForeName>J M</ForeName>
            <Initials>JM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blakley</LastName>
            <ForeName>R L</ForeName>
            <Initials>RL</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007527">Isoenzymes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.5.1.3</RegistryNumber>
          <NameOfSubstance UI="D013762">Tetrahydrofolate Dehydrogenase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>YL5FZ2Y5U1</RegistryNumber>
          <NameOfSubstance UI="D008727">Methotrexate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000937" MajorTopicYN="N">Antigen-Antibody Reactions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002846" MajorTopicYN="N">Chromatography, Affinity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008727" MajorTopicYN="N">Methotrexate</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013762" MajorTopicYN="N">Tetrahydrofolate Dehydrogenase</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">45</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00695a005</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">46</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>24</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Dec</Month>
              <Day>02</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Purification and properties of Escherichia coli dihydrofolate reductase.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5267-73</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Dihydrofolate reductase has been purified 40-fold to apparent homogeneity from a trimethoprim-resistant strain of Escherichia coli (RT 500) using a procedure that includes methotrexate affinity column chromatography. Determinations of the molecular weight of the enzyme based on its amino acid composition, sedimentation velocity, and sodium dodecyl sulfate gel electrophoresis gave values of 17680, 17470 and 18300, respectively. An aggregated form of the enzyme with a low specific activity can be separated from the monomer by gel filtration; treatment of the aggregate with mercaptoethanol or dithiothreitol results in an increase in enzymic activity and a regeneration of the monomer. Also, multiple molecular forms of the monomer have been detected by polyacrylamide gel electrophoresis. The unresolved enzyme exhibits two pH optima (pH 4.5 and pH 7.0) with dihydrofolate as a substrate. Highest activities are observed in buffers containing large organic cations. In 100 mM imidazolium chloride (pH 7), the specific activity is 47 mumol of dihydrofolate reduced per min per mg at 30 degrees. Folic acid also serves as a substrate with a single pH optimum of pH 4.5. At this pH the Km for folate is 16 muM, and the Vmax is 1/1000 of the rate observed with dihydrofolate as the substrate. Monovalent cations (Na+, K+, Rb+, and Cs+) inhibit dihydrofolate reductase; at a given ionic strength the degree of inhibition is a function of the ionic radius of the cation. Divalent cations are more potent inhibitors; the I50 of BaCl2 is 250 muM, as compared to 125 mM for KCl. Anions neither inhibit nor activate the enzyme.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Baccanari</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Phillips</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sinski</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burchall</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007527">Isoenzymes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D046911">Macromolecular Substances</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>451W47IQ8X</RegistryNumber>
          <NameOfSubstance UI="D012965">Sodium Chloride</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>660YQ98I10</RegistryNumber>
          <NameOfSubstance UI="D011189">Potassium Chloride</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.5.1.3</RegistryNumber>
          <NameOfSubstance UI="D013762">Tetrahydrofolate Dehydrogenase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>YL5FZ2Y5U1</RegistryNumber>
          <NameOfSubstance UI="D008727">Methotrexate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002846" MajorTopicYN="N">Chromatography, Affinity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D046911" MajorTopicYN="N">Macromolecular Substances</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008727" MajorTopicYN="N">Methotrexate</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009994" MajorTopicYN="N">Osmolar Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011189" MajorTopicYN="N">Potassium Chloride</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012965" MajorTopicYN="N">Sodium Chloride</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013762" MajorTopicYN="N">Tetrahydrofolate Dehydrogenase</DescriptorName>
          <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">46</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00695a006</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">47</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>24</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Dec</Month>
              <Day>02</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The influence of pH on the interaction of inhibitors with triosephosphate isomerase and determination of the pKa of the active-site carboxyl group.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5274-9</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Ionization effects on the binding of the potential transition state analogues 2-phosphoglycolate and 2-phosphoglycolohydroxamate appear to be attributable to the changing state of ionization of the ligands themselves, therefore it is unnecessary to postulate the additional involvement of an ionizing residue at the active site of triosephosphate isomerase to explain the influence of changing pH on Ki in the neutral range. The binding of the competitive inhibitor inorganic sulfate is insensitive to changing pH in the neutral range. 3-Chloroacetol sulfate, synthesized as an active-site-specific reagent for triosephosphate isomerase, is used to provide an indication of the pKa of the essential carboxyl group of this enzyme. Previously described active-site-specific reagents for the isomerase were phosphate esters, and their changing state of ionization (accompanied by possible changes in their affinity for the active site) may have complicated earlier attempts to determine the pKa of the essential carboxyl group from the pH dependence of the rate of inactivation. Being a strong monoprotic acid, chloroacetol sulfate is better suited to the determination of the pKa of the carboxyl group. Chloroacetol sulfate inactivates triosephosphate isomerase by the selective esterification of the same carboxyl group as that which is esterified by the phosphate esters described earlier. From the pH dependence of the rate of inactivation of yeast triosephosphate isomerase, the apparent pKa of the active-site carboxyl group is estimated as 3.9 +/- 0.1.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hartman</LastName>
            <ForeName>F C</ForeName>
            <Initials>FC</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>LaMuraglia</LastName>
            <ForeName>G M</ForeName>
            <Initials>GM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tomozawa</LastName>
            <ForeName>Y</ForeName>
            <Initials>Y</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wolfenden</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006902">Hydroxymercuribenzoates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9BZQ3U62JX</RegistryNumber>
          <NameOfSubstance UI="D004228">Dithionitrobenzoic Acid</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 5.1.3.-</RegistryNumber>
          <NameOfSubstance UI="D002238">Carbohydrate Epimerases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 5.3.1.1</RegistryNumber>
          <NameOfSubstance UI="D014305">Triose-Phosphate Isomerase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002238" MajorTopicYN="N">Carbohydrate Epimerases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004228" MajorTopicYN="N">Dithionitrobenzoic Acid</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006902" MajorTopicYN="N">Hydroxymercuribenzoates</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011817" MajorTopicYN="N">Rabbits</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014305" MajorTopicYN="N">Triose-Phosphate Isomerase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">47</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00695a007</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">48</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>24</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Dec</Month>
              <Day>02</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Monoanion inhibition and 35Cl nuclear magnetic resonance studies of renal dipeptidase.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5280-5</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Kinetic analyses of monoanion inhibition and 15Cl nuclear magnetic resonance at 5.88 MHz were employed to study monoanion interactions with the zinc metalloenzyme, renal dipeptidase. The enzyme-catalyzed hydrolysis of glycyldehydrophenylalanine exhibited competitive inhibition when the reaction rate was determined in the presence of the monovalent anions fluoride, chloride, bromide, iodide, azide, nitrate, or thiocyanate or upon the addition of the divalent anion, sulfate. Competitive inhibition was produced by these anions. One anion was bound per enzyme molecule, and except in the case of fluoride all of the anions appeared to bind at the same site. Cyanide ion produced a much more effective inhibition of renal dipeptidase than the other monoanions, and it was shown that two cyanide ions were bound per enzyme molecule. An investigation of the effect of pH upon monoanion inhibition suggested that the anion inhibitors bind to the group with a pK of approximately 7.8. Complete dissociation of this group (approximately pH 8.4) eliminates the inhibitory effect of anions. The 35Cl line broadening produced by renal dipeptidase in 0.5 M NaCl solutions was 100 times more effective than that produced by equivalent concentrations of aquozinc(II). The line broadening was dependent upon the concentration of the metalloenzyme and independent of the frequency of the exciting radiation. When zinc ion was removed from the metalloenzyme by dialysis or when chloride was titrated from the metalloenzyme by cyanide, line broadening was decreased. Treatment of renal dipeptidase with saturating concentrations of the competitive inhibitor, guanosine triphosphate, in the presence of 0.5 M NaCl also produced a significant decrease in the 35Cl line width. The 35Cl line broadening produced by renal dipeptidase was shown to decrease with increasing pH through the range pH 5.8-10.8. This line-width variation with pH appeared to result from the titration of a site on the metalloprotein with an approximate pK of 7.4. Temperature studies of 35Cl line broadening by the metalloenzyme in the presence of chloride and cyanide inhibitors suggest that the fast exchange process pertains and that the dominant relaxation mechanism is quadrupolar in nature.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ferren</LastName>
            <ForeName>L G</ForeName>
            <Initials>LG</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ward</LastName>
            <ForeName>R L</ForeName>
            <Initials>RL</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Campbell</LastName>
            <ForeName>B J</ForeName>
            <Initials>BJ</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000838">Anions</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001386">Azides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001965">Bromides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002712">Chlorides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003486">Cyanides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007454">Iodides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009566">Nitrates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013431">Sulfates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013861">Thiocyanates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.13.-</RegistryNumber>
          <NameOfSubstance UI="D004150">Dipeptidases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>Q80VPU408O</RegistryNumber>
          <NameOfSubstance UI="D005459">Fluorides</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000838" MajorTopicYN="Y">Anions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001386" MajorTopicYN="N">Azides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001965" MajorTopicYN="N">Bromides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002712" MajorTopicYN="N">Chlorides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003486" MajorTopicYN="N">Cyanides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004150" MajorTopicYN="Y">Dipeptidases</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005459" MajorTopicYN="N">Fluorides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007454" MajorTopicYN="N">Iodides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007672" MajorTopicYN="N">Kidney Cortex</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008433" MajorTopicYN="N">Mathematics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009566" MajorTopicYN="N">Nitrates</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013431" MajorTopicYN="N">Sulfates</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013861" MajorTopicYN="N">Thiocyanates</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">48</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00695a008</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Med Educ. 2002 Oct;36(10):972-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12390466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Care. 2004 Mar;42(3):259-66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15076825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Educ. 2004 Sep;38(9):1006-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15327684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fam Pract. 2005 Jun;22(3):328-34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15772120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Educ. 2005 Aug;39(8):820-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16048624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Gen Pract. 2006 Apr;56(525):262-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16611514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Educ. 2008 Apr;42(4):364-73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18338989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nurse Educ Pract. 2008 Sep;8(5):299-301</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18692016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Intern Med. 1995 Nov 15;123(10):795-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7574198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 1995 Aug 5;311(7001):376-80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7640549</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">49</PMID>
      <DateCompleted>
        <Year>1976</Year>
        <Month>02</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0006-2960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>24</Issue>
            <PubDate>
              <Year>1975</Year>
              <Month>Dec</Month>
              <Day>02</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemistry</Title>
          <ISOAbbreviation>Biochemistry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme.</ArticleTitle>
        <Pagination>
          <MedlinePgn>5294-9</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Bovine erythrocyte superoxide dismutase was slowly and irreversibly inactivated by hydrogen peroxide. The rate of this inactivation was directly dependent upon the concentrations of both H2O2 and of enzyme, and its second-order rate constant at pH 10.0 and 25 degrees was 6.7 M-1 sec-1. Inactivation was preceded by a bleaching due to rapid reduction of Cu2+ on the enzyme, and following this there was a gradual reappearance of a new absorption in the visible region, which was coincident with the loss of catalytic activity. Inactivation of the enzyme was pH-dependent and indicated an essential ionization whose pKa was approximately 10.2. Replacement of H2O by D2O raised this pKa but did not diminish the catalytic activity of superoxide dismutase, measured at pH 10.0. Several compounds, including xanthine, urate, formate, and azide, protected the enzyme against inactivation by H2O2. Alcohols and benzoate, which scavenge hydroxyl radical, did not protect. Compounds with special affinity for singlet oxygen were similarly ineffective. The data were interpreted in terms of the reduction of the enzyme-bound Cu2+ to Cu+, by H2O2, followed by a Fenton's type reaction of the Cu+ with additional H2O2. This would generate Cu2+-OH- or its ionized equivalent, Cu2+-O--, which could then oxidatively attack an adjacent histidine and thus inactivate the enzyme. Compounds which protected the enzyme could have done so by reacting with the bound oxidant, in competition with the adjacent histidine.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hodgson</LastName>
            <ForeName>E K</ForeName>
            <Initials>EK</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fridovich</LastName>
            <ForeName>I</ForeName>
            <Initials>I</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biochemistry</MedlineTA>
        <NlmUniqueID>0370623</NlmUniqueID>
        <ISSNLinking>0006-2960</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>BBX060AN9V</RegistryNumber>
          <NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.15.1.1</RegistryNumber>
          <NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013053" MajorTopicYN="N">Spectrophotometry</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013056" MajorTopicYN="N">Spectrophotometry, Ultraviolet</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
          <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1975</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">49</ArticleId>
        <ArticleId IdType="doi">10.1021/bi00695a010</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>JAMA. 2001 Nov 14;286(18):2322-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11710899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 2002 Jan 31;415(6871):530-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11823860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genet Med. 2002 Mar-Apr;4(2):43-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11882780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur Heart J. 2003 Mar;24(6):560-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12643889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Rev Cancer. 2004 May;4(5):361-70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15122207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Genet. 2006 Mar;38(3):337-42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16444271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genet Med. 2006 Feb;8(2):109-15</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16481894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Genet. 2006 Apr;38(4):441-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16550169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 2007 Jun 7;447(7145):661-78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17554300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Educ. 2007 Jul;41(7):698-702</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17614891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am Heart J. 2007 Oct;154(4):624-31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17892982</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
